¡ÖÃκâ´ÉÍý¡×»ï

Ãκâ´ÉÍý¡¡2008ǯ¡¡Ç¯´Ö¤ÎÌܼ¡

ANNUAL INDEX OF CONTENTS¡Ê2008¡Ë
INTELLECTUAL PROPERTY MANAGEMENT VOL.58

ÆüËÜÃÎŪºâ»º¶¨²ñ¡¡JAPAN INTELLECTUAL PROPERTY ASSOCIATION
Ê¿ À® 20 ǯ ÃÎ ºâ ´É Íý Áí ÌÜ ¼¡¡¡Vol.58¡Ê2008¡Ë

¡½ ǯ¡¡Æ¬¡¡°§¡¡»¢ ¡½

ÊÇ¡¡¡¡¹æ
ǯƬ½ê´¶ ÆõöģĹ´±
Èî¡¡ÄÍ¡¡²í¡¡Çî
1(1)
ǯƬ°§»¢ ²ñ¡¡Ä¹
Ìî´Ö¸ý¡¡¡¡¡¡Í­
3(1)

¡½´¬¡¡¡¡Æ¬¡¡¡¡¸À¡½

ÊÇ¡¡¡¡¹æ
ȯÌÀ¤¹¤ë¿´¤ò°é¤à¤¿¤á¤Ë Ã桡¼¡¡Æ»¡¡±Ò 151(2)
À½Éʳ«È¯¤Ë¤ª¤±¤ëÃÎŪºâ»º¤ÎÌò³ä °Ë¡¡²ì¡¡¡¡¡¡ âà 311(3)
ɸ½à²½¤ÈÃÎŪºâ»º¸¢ ¾®¡¡Ìî¡¡¹À¡¡Ê¿ 459(4)
»ñÀ¸Æ²¤Ë¤ª¤±¤ëÃκâÀïά Åìµ×ÊÝ¡¡Ï¡¡Íº 569(5)
²ñ¼Ò·Ð±Ä¤Ë¹×¸¥¤¹¤ëÃÎŪºâ»º³èÆ° °Â¡¡À´¡¡°ì¡¡Èþ 701(6)
MOT¤Î»ëÅÀ¤ÈÃÎŪºâ»º¸¢ Ãæ¡¡Ìî¡¡¹Ì¡¡ºî 1005(8)
ÃÎŪºâ»º¤ò°Õ¼±¤·¤¿¤â¤Î¤Å¤¯¤ê ÀС¡°æ¡¡²í¡¡¼£ 1127(9)
¸øŪ¸¦µæµ¡´Ø¤Î¥¤¥Î¥Ù¡¼¥·¥ç¥ó¡¢¤½¤Î¥Ð¥È¥ó¥¾¡¼¥ó ã·¡¡Æ£¡¡ÌС¡Ï 1247(10)
¥µ¡¼¥Ó¥¹¶È¤Ë¤ª¤±¤ëÃÎŪºâ»º´ÉÍý Á°¡¡ÅÄ¡¡½¤¡¡»Ê 1391(11)
DOWA¥Û¡¼¥ë¥Ç¥£¥ó¥°¥¹¤Ë¤ª¤±¤ëÃκâÀïά ̾¡¡Â¼¡¡¡¡¡¡ Í¥ 1537(12)

¡½ °§¡¡¡¡¡¡¡¡»¢ ¡½

ÊÇ¡¡¡¡¹æ
¡Ê5·î30Æü¡¡ÄêÎãÁí²ñ¡Ë
°§¡¡¡¡»¢ ²ñ¡¡Ä¹
Ìî´Ö¸ý¡¡¡¡¡¡Í­
831(7)
½¢Ç¤°§»¢ Éû²ñĹ
ÉÙ¡¡Ìľ¡¡¼ù
833(7)
½¢Ç¤°§»¢ Éû²ñĹ
¾¾¡¡”³¡¡¡¡¡¡ ¾¼
834(7)
2007ǯÅÙ¶È̳Êó¹ð Á°Íý»öĹ
²Ã¡¡Æ£¡¡ÂÙ¡¡½õ
835(7)
2008ǯÅÙ±¿±ÄÊý¿Ë Íý»öĹ
±°¡¡É¹¡¡Íµ¡¡É§
838(7)
¼Õ¡¡¡¡¼­ Èïɽ¾´¼ÔÂåɽ
»Ö¡¡Â¼¡¡¡¡¡¡ ͦ
845(7)

¡½ Æý¸¡§Ãκâ¥ê¥¹¥¯¤Ë¤É¤¦Âбþ¤¹¤Ù¤­¤« ¡½

ÊÇ¡¡¡¡¹æ
Æý¸¡ÖÃκâ¥ê¥¹¥¯¤Ë¤É¤¦Âбþ¤¹¤Ù¤­¤«¡×¤Î´ë²è¤Ë¤¢¤¿¤Ã¤Æ ²ñ»ï¹­Êó°Ñ°÷²ñ 313(3)

¡½ Æ᡽¸¡¡ÏÀ¡¡Àâ ¡½

ÊÇ¡¡¡¡¹æ
ÆüËÜ´ë¶È¤¬¼è¤ë¤Ù¤­²¤½£¤Ë¤ª¤±¤ëÆõöÁʾÙÀïά¤Ë¤Ä¤¤¤Æ ÊÒ»³¡¡±ÑÆó
Âç·î¡¡²íÇî
ÉþÉô¡¡¡¡À¿
315(3)
ÊÑËƤ¹¤ëÊƹñÆõöÀ©ÅÙ¡¦±¿ÍѤȤ½¤ÎÂкö¤ÎÊý¸þ Éþ¡¡Éô¡¡·ò¡¡°ì 339(3)
¹ñºÝµ»½Ñ°Üž¤Ëȼ¤¦µ»½Ñή½ÐÂкö
¨¡¨¡¡¡Ãæ¹ñ¤Ø¤Îµ»½Ñ°Üž¤Ë¤Ä¤¤¤Æ¤Î
α°Õ¤¹¤Ù¤­À©ÅÙ¾å¤ÎÌäÂêÅÀ¡¡¨¡¨¡
¥Õ¥§¥¢¥È¥ì¡¼¥É°Ñ°÷²ñ 359(3)
ɬ¿ÜÆõö¥Ý¡¼¥È¥Õ¥©¥ê¥ªÏÀ¤È¤³¤ì¤Ë´ð¤Å¤¯M¡õA¤Ë¤ª¤±¤ë
¥ê¥¹¥¯¹Í»¡¤Ë´Ø¤·¤Æ
»­ÅçÀµÍÎ
´äºêÍÎÊ¿
375(3)
Éôºà¤Î¾ùÅÏ¡¦ÉôºàÆõö¤Î¼Â»ÜµöÂú¤È´°À®ÉÊÆõö¤Ë¤è¤ë¸¢Íø¹Ô»È
¨¡¨¡¡¡¾Ã¿Ô¤ÈÌÛ¼¨¤Î¼Â»ÜµöÂú¤ÎÀ®Î©ÈϰϤ˴ؤ¹¤ë¸¡Æ¤¡¡¨¡¨¡
½Å¡¡ÉÚ¡¡µ®¡¡¸÷ 387(3)
¥³¥ó¥Æ¥ó¥ÄÍøÍѼԸþ¤±¥µ¡¼¥Ó¥¹¤Ë¤ª¤±¤ëÃøºî¸¢¿¯³²¤ÎÌäÂê
¨¡¨¡¡¡Ã¯¤¬¿¯³²¼Ô¤È¤Ê¤ë¤Î¤«¡©¡¡¨¡¨¡
¥Ç¥¸¥¿¥ë¥³¥ó¥Æ¥ó¥Ä°Ñ°÷²ñ 399(3)

¡½ ÏÀ¡¡¡¡¡¡¡¡¡¡Àâ ¡½

ÊÇ¡¡¡¡¹æ
ÊƹñÆõöË¡¤Ë¤ª¤±¤ëÈó¼«ÌÀÀ­¡§
KSRºÇ¹âºÛȽ·è¤ÎÎò»ËŪ°ÕµÁ
ÃÝ¡¡Ãæ¡¡½Ó¡¡»Ò 5(1)
¥á¥¿¥Ð¡¼¥¹Ê¸²½¤ÈÃÎŪºâ»º ÉÍ¡¡ÅÄ¡¡¼£¡¡Íº 21(1)
¥½¥Õ¥È¥¦¥§¥¢Æõö¤Ë¤è¤ë¥¤¥Î¥Ù¡¼¥·¥ç¥ó¤ÎÂ¥¿Ê¤ª¤è¤Ó
Á˳²¤Ë¤Ä¤¤¤Æ¤Î°ì¹Í»¡
¨¡¨¡¡¡Æä˥饤¥»¥ó¥·¡¼Êݸî¤Î´ÑÅÀ¤«¤é¨¡¨¡
Ê¿¡¡ÄÍ¡¡»°¡¡¹¥ 31(1)
»º³èË¡¤Ë¤è¤ë¿·¤¿¤ÊÊñ³ç·¿ÅÐÏ¿À©Å٤ȥ饤¥»¥ó¥¹
¼è°ú¤ò¤á¤°¤ëÌäÂêÅÀ¤Ë¤Ä¤¤¤Æ
¾¾¡¡ÅÄ¡¡½Ó¡¡¼£ 41(1)
EPCË¡²þÀµ¤È½ÅÍ׿³·è¤Î¾Ò²ð ¹ñºÝÂè2°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
55(1)
ÊƹñÁʾ٤ˤª¤±¤ë½éÆ°Âбþ
¨¡¨¡¡¡¡ÖÁʾ٥ۡ¼¥ë¥É¡×¤Ë¤è¤ë¾ÚµòÊÝÁ´¤È¡¢ÊÛ¸î»Î¡¦
°ÍÍê¼Ô´ÖÈëÆ¿Æø¢¤È¥ï¡¼¥¯¥×¥í¥À¥¯¥ÈË¡Íý¤Î³èÍѨ¡¨¡
°ì¡¡¿§¡¡ÂÀ¡¡Ïº 153(2)
´ë¶È¤Ë¤ª¤±¤ë¥Ç¥¶¥¤¥óÊݸî¤Î¸½¾õ¤ÈÀïάŪ°Õ¾¢½Ð´ê ²¸¡¡ÅÄ¡¡Çî¡¡Àë 163(2)
ÃκâÀìÌç¿Íºà¤Î²ÝÂê¤È¼ÒÆâÊÛÍý»Î¤Ø¤Î´üÂÔ
¨¡¨¡¡¡Ãκâ¶È̳¥¦¥¤¥ó¥°¤Î¹­¤¬¤ê¤òµá¤á¤Æ¨¡¨¡
°æ¡¡¾å¡¡¡¡¡¡°ì 181(2)
¾¦ÉʤÎΩÂÎŪ·Á¾õ¤Î¤ß¤«¤é¤Ê¤ë¾¦É¸¤ÎÅÐÏ¿Í×·ïȽÃǤδð½à¤Î¹ÔÊý
¨¡¨¡¡¡¥ß¥Ë¥Þ¥°¥é¥¤¥ÈȽ·è¹Í¨¡¨¡
¸÷¡¡Ìʸ¡¡»Ò 191(2)
Æõö¿³ºº¥Ï¥¤¥¦¥§¥¤¤Ë´Ø¤¹¤ëÍøÍѼÂÂÖÄ´ºº¤ª¤è¤ÓÄó¸À ÆõöÂè1°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
201(2)
»º³ØÏ¢·È¤Ë¤ª¤±¤ëÃÎŪºâ»º¤Î¸ú²ÌŪ¼ÂÍѲ½¥¹¥­¡¼¥à¹½Ãۤظþ¤±¤¿»î¹Ô
¨¡¨¡¡¡ÁÈ¿¥Âбþ·¿Ï¢·È¤Î»ÅÁȤߤòÍøÍѤ·¤¿»îÌô¤Î¿×®¤ÊÀ½Éʲ½¨¡¨¡
°ËÆ£¡¡ÈÏÇ·
»³Æâ¡¡¡¡¹±
¸ÅÀî¡¡¾¡É§
461(4)
¿¯³²Áʾ٤ˤª¤±¤ë̵¸ú¤Î¹³Êۤȼ«Í³µ»½Ñ¤Î¹³ÊÛ ËÒ¡¡Ìî¡¡ÃΡ¡É§ 471(4)
Àè»ÈÍѸ¢¤È¤½¤ÎΩ¾Ú½àÈ÷ ·¦¡¡ÅÄ¡¡±Ñ°ìϺ 483(4)
¾¦Éʲ½¸¢¤ÈÃÎŪºâ»º¸¢¤Î´Ø·¸
¨¡¨¡¡¡Êú¤¨¤ë²ÝÂê¤ÈÂкö¨¡¨¡
µí¡¡ÌÚ¡¡Íý¡¡°ì 491(4)
·Ð±Ä¤Ë»ñ¤¹¤ëÃÎŪºâ»º³èÆ°¤Î¤¢¤êÊý ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè1°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
503(4)
ÉÔÀµ¶¥ÁèËÉ»ßË¡¾å¤Î¾¦ÉÊ·ÁÂÖ¤ÎÊݸî
¨¡¨¡¡¡°Õ¾¢Ë¡¡¦¾¦É¸Ë¡Åù¤ÈÈæ³Ó¤·¤Æ¨¡¨¡
Àî¡¡À¥¡¡´´¡¡É× 571(5)
ÌÏÊïÂкö¤Ë¤ª¤±¤ëÃæ¹ñ¾¦É¸´ØÏ¢À©ÅÙ¤Îα°ÕÅÀ µÜ¡¡¸¶¡¡µ®¡¡ÍÎ 591(5)
ÁÏÌô»ö¶È´ØÏ¢¿¦Ì³È¯ÌÀÂвÁ¤Î¹Í»¡ °åÌôÉÊ»º¶È¿¦Ì³È¯ÌÀ¸¡Æ¤²ñ
ÃÝÅÄ¡¡Ì­¡Ê´Æ½¤¡Ë
603(5)
Ãæ¹ñÃøºî¸¢Ë¡¤Ë¤ª¤±¤ë¾ðÊó¥Í¥Ã¥È¥ï¡¼¥¯ÅÁ㸢¤Ë´Ø¤¹¤ë
ÌäÂêÅÀµÚ¤ÓÀ°È÷
¸Õ¡¡¡¡¡¡±À¡¡¹È 617(5)
KSRȽ·è¸å¤ÎANDAÁʾÙ
¡Ý°åÌô²½¹çʪ¤ª¤è¤ÓÁÈÀ®Êª¤Ë¤Ä¤¤¤Æ¤Î¼«ÌÀÀ­È½ÃǤÎÊÑÁ«¡Ý
¥¢¥À¥à¡¦¥µ¥Þ¥ó¥¹¥­¡¼
Çß¼¼¡¡½ß
703(6)
Ãκâ¡ÖÁϤ¡×¥×¥í¥»¥¹¤Ë¤ª¤±¤ë½ôÌäÂê¤Î¸¡Æ¤
¨¡¨¡¡¡È¯ÌÀ¤Î¼Á¤ÈÌÀºÙ½ñ¤Î¼Á¤Î¸þ¾å¤Ë»ñ¤¹¤ë
ÃκâÉôÌç¤ÎÌò³ä¤È´ØÍ¿¤Î¤¢¤êÊý¨¡¨¡
ÆõöÂè1°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
711(6)
Êƹñ¤Ë¤ª¤±¤ëÊú¤­¹ç¤ï¤»¤Ë´Ø¤¹¤ëȽÎã¤ÎÆ°¸þ¤È¼Â̳¾å¤Îα°ÕÅÀ
¡ÝÆõö»ö·ï¤òÃæ¿´¤È¤·¤Æ¡Ý
¹ñºÝÂè1°Ñ°÷²ñ 729(6)
Ãκâ¿Íºà°éÀ®¤Î¤¿¤á¤ÎÉôÌçĹ¿´ÆÀ3²Õ¾ò
¨¡¨¡¡¡¤¢¤Ê¤¿¤Î¤ä¤êÊý¤Ï¤Þ¤Á¤¬¤Ã¤Æ¤¤¤ë¨¡¨¡
ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè1°Ñ°÷²ñ
Âè3¾®°Ñ°÷²ñ
741(6)
ÉÔ¸øÀµ¹Ô°Ù¤Î¹³ÊÛµÚ¤ÓWalker Process Fraud¤ÎΩ¾ÚÍ×·ï ¹ñºÝÂè1°Ñ°÷²ñ 847(7)
¥Ù¥È¥Ê¥à¤Ë¤ª¤±¤ëÆõö¼èÆÀ¾å¤Îα°ÕÅÀ ¹ñºÝÂè3°Ñ°÷²ñ 859(7)
¹³ÂÎÆõö½Ð´ê¤Î¿³ºº¤Ë´Ø¤¹¤ëÆüÊƲ¤¤Î»°¶ËÈæ³Ó¸¦µæ ¥Ð¥¤¥ª¥Æ¥¯¥Î¥í¥¸¡¼°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
873(7)
¥Î¥¦¥Ï¥¦¤ÈÆõö¤Î·²´ÉÍý¤Ë¤è¤ëµ»½Ñή½Ð¤ÎÂбþ ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè1°Ñ°÷²ñ
Âè4¾®°Ñ°÷²ñ
899(7)
¾¦ÉÊÅùɽ¼¨¤Ë·¸¤ï¤ëˡΧÈæ³Ó ¥Õ¥§¥¢¥È¥ì¡¼¥É°Ñ°÷²ñ 913(7)
¥Ó¥¸¥Í¥¹¥â¥Ç¥ëÆõö¡¦¥Ð¥¤¥ª¥¤¥ó¥Õ¥©¥Þ¥Æ¥£¥¯¥¹Æõö¤Î¶¦ÄÌÅÀ¡¦Áê°ãÅÀ
¨¡¨¡¡¡¥Ç¡¼¥¿ÆÃÀ­¤Î°ã¤¤¤Ë¤è¤ëŬÍÑ¿³ºº´ð½à¤Îº¹°Û¤Ë¤Ä¤¤¤Æ¨¡¨¡
±ü¡¡Ìî¡¡¾´¡¡É§ 1007(8)
ÌÀºÙ½ñÅù¤Îµ­ºÜÍ×·ï¤Ë´Ø¤¹¤ëÆüËÜ¡¢Êƹñ¡¢²¤½£¡¢
Ãæ¹ñ¡¢µÚ¤Ó´Ú¹ñ¤ÎȽÃǤˤĤ¤¤Æ¤Î°ì¹Í»¡
ÆõöÂè1°Ñ°÷²ñ
Âè3¾®°Ñ°÷²ñ
1019(8)
KSRºÇ¹âºÛȽ·è¸å¤Ë¤ª¤±¤ëÊƹñ¤Ç¤Î¼«ÌÀÀ­È½ÃǤÎÆ°¸þ ¹ñºÝÂè1°Ñ°÷²ñ 1037(8)
EPO¤Ë¤ª¤±¤ë°ÛµÄ¼ê³¤Ç¤ÎÊäÀµ¤È¿³È½ÀÁµá¿ÍŬ³Ê ¹ñºÝÂè2°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1049(8)
¥°¥í¡¼¥Ð¥ë¤ÊÃÎŪºâ»º¼è°ú¤Ëȼ¤¦ÀÇ̳¤Ø¤ÎÂбþ
¨¡¨¡¡¡ÃκâÀÇ̳¤ÎÁ´ÂÎÁü¤ÎÄ󼨤È
¥°¥ë¡¼¥×´ë¶È´Ö¤Î°Üž²Á³ÊÀÇÀ©¤Ø¤ÎÂбþ¨¡¨¡
ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè2°Ñ°÷²ñ
Âè3¾®°Ñ°÷²ñ
1057(8)
¥Î¥¦¥Ï¥¦¥é¥¤¥»¥ó¥¹·ÀÌó¤Ë¤ª¤±¤ë¥é¥¤¥»¥ó¥µ¡¼¤ÎÀÕǤ¤Ë´Ø¤¹¤ë°ì¹Í»¡ ¥é¥¤¥»¥ó¥¹Âè2°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1073(8)
Ãæ¹ñÆõöÀ©ÅÙ¤ÎÊäÀµµÚ¤Ó¼Â̳¾å¤Îα°ÕÅÀ ²¿¡¡¡¡¡¡¾®¡¡èÌ 1129(9)
¸ø½°¿³ºº¤Îµ¡²ñ¤òÁˤà½ôÌäÂê¤Ë¤Ä¤¤¤Æ¤Î¸¦µæ
¨¡¨¡¡¡½Ð´ê¸ø³«Á°¤ËÆõöººÄê¤È¤Ê¤ë¾ì¹ç¤Î½ôÌäÂê¤Î¸¡Æ¤¨¡¨¡
ÆõöÂè1°Ñ°÷²ñ
Âè6¾®°Ñ°÷²ñ
1139(9)
¿¯³²Áʾ٤ˤª¤±¤ëÆõö̵¸ú¤Î¹³Êۤ覵æ
¨¡¨¡¡¡Ê¬³ä¡¦ÊäÀµÍ×·ï°ãÈ¿¤òÃæ¿´¤È¤·¤Æ¨¡¨¡
ÆõöÂè2°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1147(9)
Êƹñ¤Ë¤ª¤±¤ë¶µº¶¿¯³²¤Ë´Ø¤¹¤ëȽÎã¤ÎÆ°¸þ¤È¼Â̳¾å¤Îα°ÕÅÀ
¨¡¨¡¡¡DSUÂçË¡ÄîȽ·è¤òÃæ¿´¤È¤·¤Æ¨¡¨¡
¹ñºÝÂè1°Ñ°÷²ñ 1161(9)
¼£ÎŤÎÂÖÍͤËÆÃħ¤¬¤¢¤ë°åÌôȯÌÀ¤Î¿³ºº¤Î¸½¾õ¤È»°¶ËÈæ³Ó¡Ê¤½¤Î1¡Ë ¥Ð¥¤¥ª¥Æ¥¯¥Î¥í¥¸¡¼°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1171(9)
ÃÎŪºâ»ºÃ´Êݤò½ä¤ë¹ñºÝµ¬ÈÏ·ÁÀ®¤ÎÆ°¸þ¤Èº£¸å¤ÎŸ˾ É©¡¡¾Â¡¡¡¡¡¡¹ä 1249(10)
¥°¥ë¡¼¥×´ë¶È¤Ë¤ª¤±¤ëÃÎŪºâ»º¤Î°ì¸µ´ÉÍý¼êË¡
¨¡¨¡¡¡¿®Â÷¤ÎÍøÍѤòÃæ¿´¤È¤·¤Æ¨¡¨¡
µþËÜľ¼ù
˧¡¡Áï
1257(10)
ΩÂξ¦É¸¤ÎÅÐÏ¿Í×·ï¤Ë¤Ä¤¤¤Æ¡Ê¤½¤Î1¡Ë
¨¡¨¡¡¡Coca¡¾ColaΩÂξ¦É¸»ö·ï¨¡¨¡
ÅļÁ±Ç·
έ¡¡ÚüÐê
1267(10)
ÊäÀµ¤Ë¤ª¤±¤ë¿·µ¬»ö¹àÄɲäÎȽÃǤˤĤ¤¤Æ ÆõöÂè1°Ñ°÷²ñ
Âè4¾®°Ñ°÷²ñ
1279(10)
¶¥¹ç¾¼Ò¤Î¼è°úÀè¤Ø¤Î·Ù¹ð¤¬±Ä¶ÈÈðëî¹Ô°Ù¤È
¤ß¤Ê¤µ¤ì¤Ê¤¤¤¿¤á¤Îα°ÕÅÀ
ÆõöÂè2°Ñ°÷²ñ
Âè6¾®°Ñ°÷²ñ
1299(10)
¼£ÎŤÎÂÖÍͤËÆÃħ¤¬¤¢¤ë°åÌôȯÌÀ¤Î¿³ºº¤Î¸½¾õ¤È»°¶ËÈæ³Ó
¡Ê¤½¤Î2¡Ë¡Ê´°¡Ë
¥Ð¥¤¥ª¥Æ¥¯¥Î¥í¥¸¡¼°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1311(10)
¥°¥ë¡¼¥×´ë¶È²ÁÃͺÇÂç²½¤Ë¸þ¤±¤¿¥°¥ë¡¼¥×Ãκâ¥Þ¥Í¥¸¥á¥ó¥È¤Ë´Ø¤¹¤ë
°ì¹Í»¡
¨¡¨¡¡¡ÃκâÁÈ¿¥¡¦µ¡Ç½¡¦¸¢Íøµ¢Â°¤Î½¸Ã桦ʬ»¶¤ÎÁªÂòÊýË¡¨¡¨¡
ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè2°Ñ°÷²ñ
Âè1¾®°Ñ°÷²ñ
1327(10)
Àïά¤Ë±þ¤¸¤¿ÈëÌ©ÊÝ»ý¾ò¹à¤Îα°ÕÅÀ ¥é¥¤¥»¥ó¥¹Âè1°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
1339(10)
ΩÂξ¦É¸¤ÎÅÐÏ¿Í×·ï¤Ë¤Ä¤¤¤Æ¡Ê¤½¤Î2¡Ë¡Ê´°¡Ë
¨¡¨¡¡¡Coca¡¾ColaΩÂξ¦É¸»ö·ï¨¡¨¡
Åļ¡¡Á±Ç·
έ¡¡¡¡ÚüÐê
1393(11)
ÆõöË¡¤Ë¤ª¤±¤ë¡Ö¾ùÅϡ׹԰ٳµÇ°¤Ë¤Ä¤¤¤Æ¤Î°ì¹Í»¡ ËÒ¡¡Ìî¡¡ÃΡ¡É§ 1405(11)
ÃÎŪºâ»º¤Ë¤è¤ë»ñ¶âĴã ÅÚ¡¡À¸¡¡Å¯¡¡Ìé 1421(11)
Æõö¥Ó¥¸¥å¥¢¥é¥¤¥¼¡¼¥·¥ç¥ó
¨¡¨¡¡¡¥¨¥ì¥¯¥È¥í¥Ë¥¯¥¹¡¦¥½¥Õ¥È¥¦¥¨¥¢Ê¬Ìî¤Ë¤ª¤±¤ëÃκâÀïά¨¡¨¡
ζ¡¡²Ú¡¡ÌÀ¡¡Íµ 1435(11)
¿³ºº´ð½à¤«¤é¤ß¤¿¿³ºº¥×¥í¥»¥¹¤Ë´Ø¤¹¤ë¸¡Æ¤
¨¡¨¡¡¡¥µ¥Ý¡¼¥ÈÍ×·ï¤È¼Â»Ü²ÄǽÍ×·ï¤Ë´Ø¤·¤Æ¨¡¨¡
ÆõöÂè1°Ñ°÷²ñ
Âè6¾®°Ñ°÷²ñ
1455(11)
ÄûÀµ¿³È½¡¦ÄûÀµ¤ÎÀÁµá¤ÈÆõö¸¢¿¯³²Áʾ٤Ȥδط¸¤Ë¤Ä¤¤¤Æ
¨¡¨¡¡¡ÄûÀµ¤Ë¤è¤ëÆõö¸¢¿¯³²Áʾ٤ο³Íý´ü´Ö¤ÎĹ´ü²½¤È¡¢
ÄûÀµ²ó¿ô¤ÎÀ©¸Â¤Ë¤Ä¤¤¤Æ¨¡¨¡
ÆõöÂè2°Ñ°÷²ñ
Âè5¾®°Ñ°÷²ñ
1471(11)
´ë¶È¤ÎÃÎŪºâ»º¤Î¸½¾ì¤«¤é¸«¤¿ËÜÅö¤ËɬÍפÊÃÎŪºâ»ºÀ¯ºö
¨¡¨¡¡¡ÃÎŪºâ»ºÀ©Å٥桼¥¶¡¼¤«¤é¤ÎÌäÂêÄ󵯨¡¨¡
ÃÎŪºâ»º¥Þ¥Í¥¸¥á¥ó¥ÈÂè2°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
1487(11)
ÊƹñÃκâ¥Þ¥Í¡¼¥¸¥á¥ó¥È
¨¡¨¡¡¡¥¿¥¤¥à¡¦¥Á¥ã¡¼¥¸¤Îæ«¡¢ÆüËܦ¤Î¸í²ò¨¡¨¡
µÈÅÄ¡¡Å¯
¥Ç¥Ó¥Ã¥É E. ¥í¥Ó¥ó¥½¥ó
1539(12)
Àè¹Ôµ»½ÑÄ´ºº¤Ë¤Ä¤¤¤Æ¤Î¹Í»¡
¨¡¨¡¡¡Â¾¼ÒÆõö¤ËÂФ¹¤ëÀè¹Ôµ»½ÑÄ´ºº¤Î¼ê³Ý¤«¤ê¤È¤·¤Æ¨¡¨¡
ÆõöÂè1°Ñ°÷²ñ
Âè5¾®°Ñ°÷²ñ
1555(12)
¥­¥ë¥Ó¡¼È½·è°Ê¸å¤ÎÆõö¸¢¿¯³²Áʾ٤ˤª¤±¤ë¥¯¥ì¡¼¥à²ò¼á¤Ë¤Ä¤¤¤Æ
¨¡¨¡¡¡Í­¸úÀ­È½ÃǤ¬¥¤¹æ¤Î°ÈÝȽÃǤËÍ¿¤¨¤ë±Æ¶Á¨¡¨¡
ÆõöÂè2°Ñ°÷²ñ
Âè4¾®°Ñ°÷²ñ
1567(12)

¡½ ȽÎã¤È¼Â̳¥·¥ê¡¼¥º ¡½

ÊÇ¡¡¡¡¹æ
No.348
¥Ô¡¼¥¿¡¼¥é¥Ó¥Ã¥ÈÃøºî¸¢É½¼¨»ö·ï
ºä¡¡ÅÄ ¡¡¡¡¡¡¶Ñ 67(1)
No.349
¹ñ³°À¸»º¤Î¤¿¤á¤Î´ð´´ÉôÉʤÎÍ¢½Ð
´ä¡¡ÄÚ ¡¡¡¡¡¡Å¯ 211(2)
No.350
·ÀÌó¤Î¹´Â«ÎϤ¬ÁèÅÀ¤È¤Ê¤Ã¤¿»öÎã
¾¾¡¡ËÜ¡¡¡¡¡¡ »Ê 519(4)
No.351
¡Ö¼è°ú¼Â¾ð¡×¤ò¹Íθ¤·¤¿»ØÄ꾦Éʤ˴ؤ¹¤ë¸¡Æ¤¡¦¹Í»¡
¨¡¨¡¡ÖIJǽÎϡ׿³·è¼è¾ÃÀÁµáÁʾٻö·ï¨¡¨¡
×¢¡¡ÅÄ¡¡Èþ¡¡Êæ 625(5)
No.352
Æü¾ïÀ¸³è¤Ç»£±Æ¤µ¤ì¤¿¥¹¥Ê¥Ã¥×¾ÓÁü¼Ì¿¿¤Î
ÍøÍѹ԰٤ˤĤ¤¤ÆÃøºî¸¢¿¯³²¤¬Ç§¤á¤é¤ì¤¿»öÎã
°æ¡¡´Ø¡¡Îá¡»Ò 757(6)
No.353
Æõö¸¢¤Î¸³´ü´Ö¤Î±äĹÅÐÏ¿½Ð´ê
¨¡¨¡2ÅÙÌܰʹߤÎÀ½Â¤¾µÇ§¤Ë´ð¤Å¤¤¤Æ
±äĹÅÐÏ¿¤ò¼õ¤±¤ë¤³¤È¤¬¤Ç¤­¤ë¤«¨¡¨¡
»°¡¡»Þ¡¡±Ñ¡¡Æó 923(7)
No.354
¾Ã¿Ô¤¬ÌäÂê¤È¤Ê¤Ã¤¿ÆõöÀ½ÉʤȤ½¤ÎÌÀºÙ½ñ
ÁÒ¡¡Æâ¡¡µÁ¡¡Ï¯ 1087(8)
No.355
ÆõöË¡112¾ò¤Î2Âè1¹à¤Ë¤è¤ëÆõö¸¢¤Î²óÉü
¨¡¨¡¡Ö¤½¤ÎÀÕ¤á¤Ëµ¢¤¹¤ë¤³¤È¤¬¤Ç¤­¤Ê¤¤Íýͳ¡×¨¡¨¡
¼ã¡¡¾¾¡¡ÍÛ¡¡»Ò 1189(9)
No.356
Éôʬ°Õ¾¢¤ÎÁϺîÍÆ°×À­
ÅÚ¡¡À¸¡¡¿¿¡¡Ç· 1349(10)
No.357
Ãøºî¸¢¿¯³²¤ò²óÈò¤¹¤ë¤¿¤á¤Ë¹­¹ðÀëÅÁʪ¤Î
À©ºî°ÑÂ÷¼Ô¤¬É餦¤Ù¤­Ãí°ÕµÁ̳
¿¹¡¡ÏÆ¡¡¡¡¡¡ È¥ 1503(11)
No.358
¾¦É¸Ë¡Âè3¾òÂè2¹à¤ÎȽÃǤȤ·¤Æ¿³·èÍýͳ¤Ëµ­ºÜ¤µ¤ì¤ë¤Ù¤­»ö¹à
¨¡¨¡¾¦É¸¡ÖAJ¡×¡¦¿³·è¼è¾ÃÁʾٻö·ï¨¡¨¡
¾®Ìî»û¡¡¡¡¡¡Î´ 1581(12)

¡½ Ƚ¡¡Îã¡¡¸¦¡¡µæ ¡½

ÊÇ¡¡¡¡¹æ
No.322
±ÇÁü¥³¥ó¥Æ¥ó¥Ä¤ÎÍøÍѸ¢¤Îµ¢¿ö
¨¡¨¡¥­¥ã¥í¥ëDVD»ö·ï¨¡¨¡
ÅÏ¡¡îµ¡¡¡¡¡¡ ½¤ 75(1)
No.323
10ǯ´Ö¤Î¶¥¶È¶Ø»ß¾ò¹à¤ò´Þ¤àÀ½Â¤°ÑÂ÷·ÀÌó¤ÎÍ­¸úÀ­
¤ª¤è¤Ó¤½¤Î·ÀÌó°ãÈ¿¤Ë¤è¤ë»³²³Û
º´¡¡Æ£¡¡Í´¡¡²ð 225(2)
No.324
ΩÂξ¦É¸¤ÎÅÐÏ¿Í×·ï
¨¡¨¡¥Þ¥°¥é¥¤¥ÈΩÂξ¦É¸»ö·ï¨¡¨¡
¾®¡¡Åç¡¡¡¡¡¡ Ω 529(4)
No.325
¥Ñ¥Á¥ó¥³¥²¡¼¥àµ¡Åù¤Ë¤è¤ë±Ç²è¤ÎÃøºîʪÍøÍÑ
µí¡¡ÌÚ¡¡Íý¡¡°ì 637(5)
No.326
ÃÎŪºâ»º¸¢¿¯³²Áʾ٤ˤª¤¤¤ÆÈëÌ©ÊÝ»ýÌ¿Î᤬ȯÎᤵ¤ì¤¿½é¤á¤Æ¤Î»öÎã
¨¡¨¡¥Ñ¥ë¥Ê¥Ñ¥ê¥ó¥Ê¥È¥ê¥¦¥à¸¶Ìô»ö·ï¨¡¨¡
»°¡¡»³¡¡½Ô¡¡»Ê 767(6)
No.327
¿¿ÀµÆõöÀ½ÉʤκÆÀ¸ÉʤÎÍ¢ÆþÈÎÇä¤Ë¤Ä¤­
Æõö¸¢¿¯³²¤¬Ç§¤á¤é¤ì¤¿»öÎã
¨¡¨¡¥­¥ä¥Î¥ó¥¤¥ó¥¯¥¿¥ó¥¯»ö·ï¨¡¨¡
²£¡¡»³¡¡µ×¡¡Ë§ 935(7)
No.328
ËÌÄ«Á¯¤ÎÃøºîʪ¤Ë¤Ä¤¤¤Æ²æ¤¬¹ñ¤¬Êݸ¤ë
µÁ̳¤òÉé¤ï¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
Ãã¡¡±à¡¡À®¡¡¼ù 1099(8)
No.329
¾¼ÏÂ28ǯ¤Ë¸øɽ¤µ¤ì¤¿ÃÄÂÎ̾µÁ¤Î±Ç²èÃøºîʪ¤Î¸³´ü´Ö
éá¡Î©¡¡½ç¡¡Èþ 1199(9)
No.330
¾¦ÉʤÎÊñÁõ¤Î·Á¾õ¤Ë·¸¤ë½ãΩÂξ¦É¸¤¬
¾¦É¸Ë¡3¾ò2¹à¤ÎŬÍѤò¼õ¤±¤¿»öÎã
¨¡¨¡¥³¥«¥³¡¼¥é¥Ü¥È¥ë»ö·ï¨¡¨¡
Àî¡¡À¥¡¡´´¡¡É× 1593(12)

¡½ »ñ¡¡¡¡ÎÁ ¡½

ÊÇ¡¡¡¡¹æ
ÉÔÀµ¶¥ÁèËÉ»ßË¡´ØÏ¢¤ÎºÇ¶á¤ÎȽÎã¤Ë¤Ä¤¤¤Æ ¥Õ¥§¥¢¥È¥ì¡¼¥É°Ñ°÷²ñ 89(1)
ÃκâÊѳץ꡼¥À¡¼°éÀ®¸¦½¤¤ÈÃκâÀïά¥¹¥¿¥Ã¥Õ°éÀ®¸¦½¤
¨¡¨¡ÆüËÜÃÎŪºâ»º¶¨²ñ¸¦½¤¡¡ÆÃÊÌ¥³¡¼¥¹¤Ë¤Ä¤¤¤Æ¨¡¨¡
¿Íºà°éÀ®°Ñ°÷²ñ 95(1)
¾¦É¸¡¦Ãøºîʪ¤Ë¤ª¤±¤ëÉÕµ­Åªµ­¹æ¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê3¡Ë¨¡¨¡
ÌÖ¡¡Ìͧ¡¡¹¯ 105(1)
´ÖÀÜ¿¯³²¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê4¡Ë¨¡¨¡
°Ë¡¡Åì¡¡Ãé¡¡½Å 233(2)
µ¡Ç½Åª¥¯¥ì¡¼¥à¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê5¡Ë¨¡¨¡
°æ¡¡·å¡¡Äç¡¡°ì 539(4)
¥É¥¤¥Ä¿·ÉÔÀµ¶¥ÁèËÉ»ßË¡ Dr. Frauke Henning-Bodewig¡¢
¥É¥¤¥ÄÃÎŪºâ»ºË¡¸¦µæ²ñ¡ÊÌõ¡Ë
649(5)
Ãøºî¸¢Ë¡¤Ë¤ª¤±¤ë¡Ö°úÍѡפˤĤ¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê6¡Ë¨¡¨¡
¥Ç¥¸¥¿¥ë¥³¥ó¥Æ¥ó¥Ä°Ñ°÷²ñ 667(5)
Âç³Ø¤ÎÃÎŪºâ»º³èÆ°¤Ï¡ÖÎ̤«¤é¼Á¤Ø¡×¡Ö¿ÍͲ½¡×¡ÖÍ»¹ç¡×¤¬¥­¡¼¥ï¡¼¥É Æþ¡¡¹¾¡¡ÂÙ¡¡»ê 775(6)
²¤½£Ï¢¹ç¡ÊEU¡Ë¤Ë¤ª¤±¤ëÃÎŪºâ»º¸¢³èÍѤΤ¿¤á¤Î
Ë¡À©ÅÙÀ°È÷¤Ë¤Ä¤¤¤Æ¡Ê¤½¤Î1¡Ë
¨¡¨¡¼ç¤ËÀÇ´ØÁ¼Ã֤˴ؤ¹¤ëµ¬Â§¤ËÃåÌܤ·¤Æ¨¡¨¡
¹ñºÝÂè2°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
789(6)
°Õ¾¢Ë¡ÆÃÍ­¤ÎÀ©Å٤γµÍ×
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê7¡Ë¨¡¨¡
º£¡¡°æ¡¡µ®¡¡»Ò 801(6)
²¤½£Ï¢¹ç¡ÊEU¡Ë¤Ë¤ª¤±¤ëÃÎŪºâ»º¸¢³èÍѤΤ¿¤á¤Î
Ë¡À©ÅÙÀ°È÷¤Ë¤Ä¤¤¤Æ¡Ê¤½¤Î2¡Ë¡Ê´°¡Ë
¨¡¨¡¼ç¤ËÃÎŪºâ»º¸¢¤Î¼¹¹Ô¤Ë´Ø¤¹¤ë»ØÎá¤ËÃåÌܤ·¤Æ¨¡¨¡
¹ñºÝÂè2°Ñ°÷²ñ
Âè2¾®°Ñ°÷²ñ
947(7)
¾Ã¿Ô¤Ë¤Ä¤¤¤Æ¡ÊÆõö¡Ë
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê8¡Ë¨¡¨¡
Ã桡¼¡¡¹¬¡¡»Ò 957(7)
¥×¥í¥À¥¯¥È¡¦¥Ð¥¤¡¦¥×¥í¥»¥¹¡¦¥¯¥ì¡¼¥à¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê9¡Ë¨¡¨¡
À¶¡¡¿å¡¡Àé¡¡½Õ 1105(8)
Ãæ¹ñ¤Ë¤ª¤±¤ë¥½¥Õ¥È¥¦¥§¥¢Êݸî¤ÎÄ´ººÊó¹ð ¥½¥Õ¥È¥¦¥§¥¢°Ñ°÷²ñ 1207(9)
Æó½ÅÆõö¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê10¡Ë¨¡¨¡
ºä¡¡ÅÄ¡¡ÂÙ¡¡¹° 1219(9)
¿³ºº´±¤È¤ÎÌÌÀܤˤĤ¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê11¡Ë¨¡¨¡
»³¡¡¸ý¡¡¾¼¡¡Â§ 1361(10)
¿ôÃ͸ÂÄêȯÌÀ¤Ë¤Ä¤¤¤Æ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê12¡Ë¨¡¨¡
¸¶¡¡¡¡¡¡ ͵¡¡»Ò 1515(11)
PCT¤ÎÀ©ÅÙ²þ³×¡ÊPCT¥ê¥Õ¥©¡¼¥à¡Ë¤Ë¤Ä¤¤¤Æ
¨¡¨¡À©ÅÙ²þÀµ¤Ë»ê¤Ã¤¿»ö¹à¤Î²òÀ⨡¨¡
¹ñºÝÂè2°Ñ°÷²ñ
Âè3¾®°Ñ°÷²ñ
1605(12)
ΩÂξ¦É¸¤Î¼±ÊÌÎÏ
¨¡¨¡º£¹¹Ê¹¤±¤Ê¤¤¥·¥ê¡¼¥º¡Ê13¡Ë¨¡¨¡
¼¡¡¾å¡¡¹¸¡¡°ì 1617(12)

¡½ ¤ï¤¬¼Ò¤ÎÃκâ³èÆ° ¡½

ÊÇ¡¡¡¡¹æ
NOK³ô¼°²ñ¼Ò 109(1)
ÆüËÜÅÅ»º³ô¼°²ñ¼Ò 239(2)
Åìг¹çÀ®³ô¼°²ñ¼Ò 409(3)
Æü¿·À½¹Ý³ô¼°²ñ¼Ò 543(4)
FDK³ô¼°²ñ¼Ò 673(5)
Åŵ¤²½³Ø¹©¶È³ô¼°²ñ¼Ò 807(6)
¥¹¥¿¥ó¥ì¡¼Åŵ¤³ô¼°²ñ¼Ò 963(7)
¥³¥Ù¥ë¥³·úµ¡³ô¼°²ñ¼Ò 1111(8)
ÆüËܲ½Ìô³ô¼°²ñ¼Ò 1225(9)
¥¢¥ë¥Ñ¥¤¥ó³ô¼°²ñ¼Ò 1367(10)
³ô¼°²ñ¼Ò¾®»åÀ½ºî½ê 1521(11)
ÅÄÊÕ»°É©À½Ìô³ô¼°²ñ¼Ò 1625(12)

¡½ ÃÎŪºâ»ºQ&A ¡½

ÊÇ¡¡¡¡¹æ
No.110
ÉʼïÅÐÏ¿À©Å٤ˤĤ¤¤Æ
–þ¡¡¶¶¡¡¿®¡¡·Ä 111(1)
No.111
¥¤¥ó¥¿¡¼¥Í¥Ã¥È½Ð´ê¤ÎƳÆþ¤È±¿ÍÑ
ÃÎŪºâ»º¾ðÊó
¥·¥¹¥Æ¥à°Ñ°÷²ñ
545(4)
No.112
¥í¥·¥¢¤Ë¤ª¤±¤ëÆõö¿¯³²
¹ñºÝÂè2°Ñ°÷²ñ 675(5)
No.113
¾¦ÉÊ¡¦Ìò̳¤Ë´Ø¤¹¤ë³Æ¼ïɽ¼¨¤Î´ðÁÃÃμ±
¥Õ¥§¥¢¥È¥ì¡¼¥É°Ñ°÷²ñ 965(7)
No.114
Áá´ü¿³ÍýÀ©ÅÙ¡¦Á°ÃÖÊó¹ð¤òÍøÍѤ·¤¿¿³¿Ò
ÆõöÄ£¿³È½Éô
¿³È½´ë²è¼¼
1227(9)
No.115
¥¹¡¼¥Ñ¡¼Áá´ü¿³ºº¤Î»î¹Ô³«»Ï¤Ë¤Ä¤¤¤Æ
ÆõöÄ£Æõö¿³ºº
Âè°ìÉôÄ´À°²Ý
1627(12)

¡½ ¶¨¡¡²ñ¡¡³è¡¡Æ° ¡½

ÊÇ¡¡¡¡¹æ
2007ǯÅÙ³¤³°¸¦½¤F3¥³¡¼¥¹Êó¹ð¡ÊÂè4²ó¡Ë
¨¡¨¡ÂæÏÑ¡¦´Ú¹ñ¡¦Ãæ¹ñ¤ÎÃÎŪºâ»º»ö¾ð¤Î¸¦½¤¨¡¨¡
2007ǯÅÙ³¤³°¸¦½¤ÃÄ¡ÊF3¡Ë 677(5)
2007ǯÅÙ³¤³°¸¦½¤F2¥³¡¼¥¹Êó¹ð
¨¡¨¡Ãκ⵻½Ñ¥¹¥¿¥Ã¥Õ¤Î¤¿¤á¤ÎÊƹñÆõö¸¦½¤¨¡¨¡
2007ǯÅÙ³¤³°¸¦½¤ÃÄ¡ÊF2¡Ë 809(6)
2007ǯÅÙ³¤³°¸¦½¤F5¥³¡¼¥¹Êó¹ð
¨¡¨¡Ãæ¹ñÃκ⸦½¤¨¡¨¡
2007ǯÅÙ³¤³°¸¦½¤ÃÄ¡ÊF5¡Ë 969(7)
2007ǯÅÙÆüÃæÏ¢·È²ñµÄÊó¹ð 2007ǯÅÙÆüÃæ´ë¶ÈÏ¢·ÈPJ 981(7)
2008ǯÅÙˬ²¤ÂåɽÃÄÊó¹ð ÆüËÜÃÎŪºâ»º¶¨²ñˬ²¤ÂåɽÃÄ 1229(9)

¡½ ¿·Æþ²ñ°÷¾Ò²ð ¡½

ÊÇ¡¡¡¡¹æ
³ô¼°²ñ¼Ò¥Þ¡¼¥¯¥¢¥¤¡Ê»¿½õ¡Ë 549(4)
³ô¼°²ñ¼Ò¥ª¥Ï¥é¡ÊÀµ¡Ë 549(4)
³ô¼°²ñ¼Ò¸½Â弫ư¼ÖÆüËܵ»½Ñ¸¦µæ½ê¡ÊÀµ¡Ë 549(4)
¥·¡¼¥á¥ó¥¹³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 549(4)
¥·¥í¥­¹©¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 550(4)
³ô¼°²ñ¼Ò¿·Àî¡ÊÀµ¡Ë 550(4)
³ô¼°²ñ¼ÒÆüÅ´µ»½Ñ¾ðÊ󥻥󥿡¼¡ÊÀµ¡Ë 550(4)
ÆüËÜ»³Â¼¾Ë»Ò³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 550(4)
»°À±¥À¥¤¥ä¥â¥ó¥É¹©¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 551(4)
¥¢¥¯¥·¥¹¹ñºÝÆõö¶È̳ˡ¿Í¡Ê»¿½õ¡Ë 551(4)
°ëÌî¹ñºÝÆõö¾¦É¸»ö̳½ê¡Ê»¿½õ¡Ë 551(4)
³á¹ñºÝÆõö»ö̳½ê¡Ê»¿½õ¡Ë 551(4)
¹ñΩÂç³ØË¡¿ÍÀŲ¬Âç³Ø¡Ê»¿½õ¡Ë 552(4)
¥¼¥Í¥é¥ë¡¦¥¨¥ì¥¯¥È¥ê¥Ã¥¯¡¦¥¤¥ó¥¿¡¼¥Ê¥·¥ç¥Ê¥ë¡¦¥¤¥ó¥¯¡Ê»¿½õ¡Ë 552(4)
ÄØÆõö»ö̳½ê¡Ê»¿½õ¡Ë 552(4)
NAM&NAM¹ñºÝÆõöˡΧ»ö̳½ê¡Ê»¿½õ¡Ë 552(4)
ÉþÉôÆõö»ö̳½ê¡Ê»¿½õ¡Ë 553(4)
¥Ñ¥Æ¥ó¥È¥ª¥ó¥é¥¤¥ó¥µ¡¼¥Á³ô¼°²ñ¼Ò¡Ê»¿½õ¡Ë 553(4)
ÍýÁϹñºÝÆõö»ö̳½ê¡Ê»¿½õ¡Ë 553(4)
°°²½À®¥ï¥Ã¥«¡¼¥·¥ê¥³¡¼¥ó³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1369(10)
³ô¼°²ñ¼Ò¥ô¥¡¥ì¥ª¥µ¡¼¥Þ¥ë¥·¥¹¥Æ¥à¥º¡ÊÀµ¡Ë 1369(10)
¥¢¥ó¥¸¥§¥¹MG³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1369(10)
»³ÍÛ¿§Ádzô¼°²ñ¼Ò¡ÊÀµ¡Ë 1369(10)
¿·ÆüïĽ»¶â¥¹¥Æ¥ó¥ì¥¹³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1370(10)
ÀÐÌý»ñ¸»³«È¯³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1370(10)
Sky³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1370(10)
Âç·ú¹©¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1370(10)
ÂçƱ¹©¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1371(10)
Åì¼Ç¥¨¥ì¥Ù¡¼¥¿³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1371(10)
³ô¼°²ñ¼ÒÄȲ°¡ÊÀµ¡Ë 1371(10)
¥È¥Ã¥Ñ¥ó¡¦¥Õ¥©¡¼¥à¥º³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1371(10)
¥Ê¥ß¥Ã¥¯¥¹³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1372(10)
¥Î¥Ð¥ë¥Æ¥£¥¹¥Õ¥¡¡¼¥Þ³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1372(10)
ÆüËÜ¥¹¥Ô¥ó¥É¥ëÀ½Â¤³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1372(10)
ÉٻΥ½¥Õ¥È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1372(10)
¥Õ¥¸¥Æ¥Ã¥¯³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1373(10)
ËÜÅĶâ°µ»½Ñ³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1373(10)
¸Å²Ï¥¹¥«¥¤³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1373(10)
Éð¢ÀºÌ©¹©¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1373(10)
¥á¥¿¥¦¥©¡¼¥¿¡¼³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1374(10)
³ô¼°²ñ¼Ò¥æ¥¿¥«µ»¸¦¡ÊÀµ¡Ë 1374(10)
͹ÊØ»ö¶È³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1374(10)
¥ê¥³¡¼¥Æ¥¯¥Î¥ê¥µ¡¼¥Á³ô¼°²ñ¼Ò¡ÊÀµ¡Ë 1374(10)
³ô¼°²ñ¼ÒRWS¥°¥ë¡¼¥×¡Ê»¿½õ¡Ë 1375(10)
¥¤¥ó¥¿¡¼¥Ê¥·¥ç¥Ê¥ë¥ê¥¹¥¯¥ê¥ß¥Æ¥Ã¥É¡Ê»¿½õ¡Ë 1375(10)
³ô¼°²ñ¼Ò¥¢¥¤¥Ô¡¼¥Æ¥¯¥Î¡Ê»¿½õ¡Ë 1375(10)
À¦ËܹñºÝÆõöˡΧ»ö̳½ê¡Ê»¿½õ¡Ë 1375(10)
¾®³Þ¸¶Æõö»ö̳½ê¡Ê»¿½õ¡Ë 1376(10)
¹ñΩÂç³ØË¡¿Í¿À¸ÍÂç³Ø¡Ê»¿½õ¡Ë 1376(10)
¥¯¥é¥Ã¥Ä¡¦¥­¥ó¥È¥¹¡¡¥¢¥ó¥É¡¡¥Ï¥ó¥½¥óˡΧ»ö̳½ê¡Ê»¿½õ¡Ë 1376(10)
¥³¡¼¥Æ¥Ã¥¯¹ñºÝÆõö»ö̳½ê¡Ê»¿½õ¡Ë 1376(10)
¥·¥º¥Ù¥ë¥¸¥ã¥Ñ¥ó³ô¼°²ñ¼Ò¡Ê»¿½õ¡Ë 1377(10)
ÄԴݹñºÝÆõö»ö̳½ê¡Ê»¿½õ¡Ë 1377(10)
DANIEL ADVOGADOS IP LAW FIRM¡Ê»¿½õ¡Ë 1377(10)
¹ñΩÂç³ØË¡¿ÍÉÙ»³Âç³Ø¡Ê»¿½õ¡Ë 1377(10)
»³ÃæÅÄÃæ¹ñºÝÆõö»ö̳½ê¡Ê»¿½õ¡Ë 1378(10)
¥ê¡¼¥¤¥ó¥¿¡¼¥Ê¥·¥ç¥Ê¥ëÆõöˡΧ»ö̳½ê¡Ê»¿½õ¡Ë 1378(10)

¡½ ¿· ´© ½ñ ¾Ò ²ð ¡½

ÊÇ¡¡¡¡¹æ
Æõö¤Î·Ð±Ä¡¦·ÐºÑʬÀÏ ºâÃÄË¡¿Í
ÃÎŪºâ»º¸¦µæ½êÊÔ
115(1)
Ãøºî¸¢Ë¡¾ÜÀâ¡¡Âè7ÈÇ¡¡È½Îã¤ÇÆɤà16¾Ï »°»³¡¡Íµ»°Ãø 116(2)
¹ñÆâÍ¥À踢À©Å٤γèÍÑ¥¬¥¤¥É¡ÁÍ­¸ú¤Ê¸¢Íø¼èÆÀ¤Î¤¿¤á¤Ë¡Á ÁϱÑÃÎŪºâ»º¸¦µæ½êÊÔÃø 242(2)
Ãøºî¸¢Ë¡ Ã滳¿®¹°Ãø 411(3)
±Ñʸ¥é¥¤¥»¥ó¥¹·ÀÌó¼Â̳¥Þ¥Ë¥å¥¢¥ë¡ÎÂè2ÈÇ¡Ï ¾®¹âÔè°ìÃø 555(4)
Êƹñ¤Ç¤ÎÆõöÁʾÙËɱҥޥ˥奢¥ë¡½¥¹¥È¡¼¥ê¡¼¤Ç¤ï¤«¤ë
·Ù¹ð¾õÂбþ¤Î¿´ÆÀ
´ßËÜ˧ÌéÃø 689(5)
ÃÎŪºâ»º¡¡88¤Î»ëÅÀ ¶ù鶹¯°ìÊÔÃø
ÆüËÜÃκâ³Ø²ñÃκâ³Ø¥¼¥ß¥Ê¡¼¥ëÃø
821(6)
ÃÎŪºâ»º¸¢¤Î¥°¥í¡¼¥Ð¥ë²½
¡½°åÌôÉÊ¥¢¥¯¥»¥¹¤ÈTRIPS¶¨Ä꡽
»³º¬Íµ»ÒÃø 993(7)
¥¢¥á¥ê¥«ÃÎŪºâ»º¸¢Ë¡ ¥¢¡¼¥µ¡¼¡¦R¡¦¥ß¥é¡¼¡¿¥Þ¥¤¥±¥ë¡¦H¡¦¥Ç¡¼¥Ó¥¹Ãø
Æ£Ìî¿Î»°Ìõ
994(7)
ÊƹñÆõö¿¯³²Áʾ٠¥ê¥Á¥ã¡¼¥É¡¦¥Ð¥ì¥ê¡¼¥ËÃø 1113(8)
ȽÎã¤Ç³Ø¤ÖÃøºî¸¢Ë¡ÆþÌç¡¡¼ÂÁ©ÅªÍý²ò¤ò¤á¤¶¤·¤Æ ºäÅÄ¡¡¶ÑÃø 1114(8)
¥é¥¤¥»¥ó¥·¥ó¥°Àïά¡¡ÆüËÜ´ë¶È¤ÎÃκâ¥Ó¥¸¥Í¥¹ ¹â¶¶¿­É×
ÃæÌî¹ä¼£ÊÔÃø
1235(9)
ÊƹñÆõöË¡
¡ÝȽÎã¤Ë¤è¤ëÊƹñÆõöË¡¤Î²òÀâ¡Ý
»³²¼¹°¹ËÊÔÃø 1236(9)
ÃÎŪºâ»º´Ø·¸Áʾ٠ÈÓ¼ÉÒÌÀ
ÀßÜÛδ°ìÃø
1379(10)
ÃÎŪºâ»º¤ò¤á¤°¤ë¹ñºÝÀÇ̳ –þµ×δÂÀÃø 1380(10)
ÃÎŪºâ»º¸¢Áʾ٤ˤª¤±¤ë»³²Çå½þ³Û»»Äê¤Î¼Â̳ ´¨²Ï¹¾¹§°ô´Æ½¤
±ÊÌî¼þ»Ö
ÌðÌîÉÒ¼ùÊÔ½¸
1523(11)
Ãæ¹ñ¾¦É¸¼Â̳´ðÁà ò²¡¡·¼³Ø
έ¡¡¿·±§ÊÔÃø
1524(11)
Á´Ì̲þÄû¡¡Æõö¿¯³²Áʾ٤μÂ̳ ´ØÀ¾Ë¡Î§Æõö»ö̳½êÊÔ
¼ÎÓδ°ì
¾¾ËÜ¡¡»Ê
´äÄÚ¡¡Å¯
°æ¾å͵»Ë
ÅľåÍÎÊ¿
1631(12)
ȯÌÀ¤Î¿ÊÊâÀ­¡ÁȽÃǤμÂ̳¡Á À¾Å繧´îÃø 1632(12)

¡½ ³°¹ñÆõö¥Ë¥å¡¼¥¹¡Ê¹ñºÝÂè1¡¦Âè2¡¦Âè3°Ñ°÷²ñ¡Ë¡½

ÊÇ¡¡¡¡¹æ
1¡¡·î¡¡¹æ 143¡Ê1¡Ë
ÊÆ¡¡¹ñ ÀèÎã¤Ë¤ª¤±¤ë¸Î°Õ¿¯³²¤Ë´Ø¤¹¤ëÈﵿ¿¯³²¼Ô¤ÎÃí°ÕµÁ̳¤Î´ð½à¤òʤ¤·¡¢Æõö¸¢¼Ô¦¤ËɬÍפÊΩ¾Ú¤ÎÍ×·ï¤ò¼¨¤·¤¿»öÎã
°Û¤Ê¤ëʬÌî¤Îµ»½Ñ¤ÎÁȹ礻¤«¤éºÆ¿³ºº¥¯¥ì¡¼¥à¤Ï¼«ÌÀ¤Ç¤¢¤ë¤È¤Î¿³·è¤¬»Ù»ý¤µ¤ì¤¿»öÎã
¥é¥¤¥»¥ó¥¹¤ä¥í¥¤¥ä¥ë¥Æ¥£¤òµÄÏÀ¤¹¤ëʸ½ñ¤Î¤ä¤ê¤È¤ê¤ÏÆõö̵¸ú¤Î³ÎǧÁʾ٤ˤª¤±¤ë·¸ÁèÀ­¤ÎÍ×·ï¤Ë­¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
ÆõöË¡119¾ò¤Ë´ð¤Å¤¯Í¥À踢¼çÄ¥¤Ï¡¢Àè¤Î³°¹ñ½Ð´ê»þ¤Ë¤ª¤¤¤ÆȯÌÀ¼Ô¤È½Ð´ê¿Í¤È¤Î´Ö¤Ç´ØÏ¢À­¤¬É¬ÍפǤ¢¤ë¤È¤·¤¿»öÎã
ÈóÁʾÙÅö»ö¼Ô¤¬¹µÁʤǤ­¤ë¤¿¤á¤ÎÍ×·ï¤òËþ¤¿¤¹¤«Èݤ«¤¬È½ÃǤµ¤ì¤¿»öÎã
Í¥À踢¼çÄ¥¤Î´ðÁäȤʤ볰¹ñ½Ð´ê¤Ë¤Ï¡¢¼Â»Ü²½¤Ë´Ø¤¹¤ë½¼Ê¬¤Êµ­ºÜ¤¬¤¢¤ë¤È¤·¤ÆÀèȯÌÀ¤òǧ¤á¤¿»öÎã
ÆõöÄ£¤Ï¡¢¼«¿È¤¬Åö»ö¼Ô¤Ç¤Ê¤¤Àè¤ÎÁʾ٤ˤª¤±¤ëºÛȽ½ê¤Î¥¯¥ì¡¼¥à²ò¼á¤Ë¹´Â«¤µ¤ì¤Ê¤¤¤È¤·¤¿»öÎã
ÌÀºÙ½ñ¤Îµ­ºÜ¤Ë´ð¤Å¤­¥¯¥ì¡¼¥à¤ÎÍѸì¤Î°ÕÌ£¤ò²ò¼á¤·¤ÆÈï¹ðÀ½ÉʤòÈ󿯳²¤È¤·¤¿»öÎã
2¡¡·î¡¡¹æ 301(2)
ÊÆ¡¡¹ñ ÌÀºÙ½ñ¤Î°ì´Ó¤·¤¿µ­ºÜµÚ¤Ó¿ÆÆõö¤Î¿³ºº·Ð²á¤Ë´ð¤Å¤¤¤Æ¡¢¥¯¥ì¡¼¥à¤ò¸ÂÄê²ò¼á¤·¤¿ÃϺۤÎȽ·è¤¬»Ù»ý¤µ¤ì¤¿»öÎã
ËÜÍèÈóÇ濳¿³Íý»ö¹à¤Ç¤¢¤ëȯÌÀ¼ÔŬ³Ê¤Ë¤Ä¤¤¤ÆÇ濳ºÛȽ¤ò¼õ¤±¤ë¸¢Íø¤òǧ¤á¤¿»öÎã
¥¯¥ì¡¼¥àÍѸì¤Î¡ÖÈæ³Ó¡ÊComparison¡Ë¡×¤Î²ò¼á¤Ï¡ÖľÀÜŪ¤ÊÈæ³Ó¡ÊDirect Comparison¡Ë¡×¤ò°ÕÌ£¤¹¤ëɬÍ×À­¤Ï¤Ê¤¤¤È¤·¤¿ÃϺÛȽÃǤò»Ù»ý¤·¤¿»öÎã
ÆÃÄê¤Î°ÛÀ­ÂΤòÄ´À°¤¹¤ëÊýË¡Åù¤ò¶µ¼¨¤·¤Ê¤¤ÌôÍý³Ø¤ÎÀè¹Ôʸ¸¥¤Ë¤è¤Ã¤Æ¤Ï¡¢¸÷³Ø°ÛÀ­ÂΤο·µ¬À­¤ª¤è¤ÓÈó¼«ÌÀÀ­¤ÏÈÝÄꤵ¤ì¤Ê¤¤¤È¤·¤¿ÃϺÛȽ·è¤ò»Ù»ý¤·¤¿»öÎã
¸¢ÍøÈÏ°ÏÁ´¤Æ¤Ë¤ª¤¤¤Æ¼Â»Ü²ÄǽÍ×·ï¤òËþ¤¿¤µ¤Ê¤«¤Ã¤¿¤¿¤áÆõö̵¸ú¤ÈȽÃǤ·¤¿»öÎã
Æõö¸¢¼Ô¤Ï¡¢¿³ºº¤Ë¤ª¤¤¤ÆÆõöµö²Ä¤ÎÍýͳ¤Ë±Æ¶Á¤òÍ¿¤¨¤¿¤«¤É¤¦¤«¤Ë´Ø¤ï¤é¤º¡¢¿³ººÃʳ¬¤Ç¾Ú¸À¤·¤¿ÆâÍƤ˹´Â«¤µ¤ì¤ë¤È¤·¤¿»öÎã
KSRºÇ¹âºÛȽ·è¤Ë´ð¤Å¤­¡¢Åö¶È¼Ô¤ËÃΤé¤ì¤¿Ê¬Î¥ÊýË¡¤¬¸øÃΤκ®¹çʪ¤ËŬÍѤµ¤ì¡¢¼«ÌÀÀ­¤¬ÈÝÄꤵ¤ì¤¿»öÎã
ÌÀºÙ½ñ¤ÎÂåÂص»½Ñ¤Ø¤ÎÈÝÄêŪ¤Êɽ¸½¤ò´ð¤Ëʸ¸À¿¯³²¡¢¶ÑÅùÏÀ¤ÎŬÍѤ¬ÈÝÄꤵ¤ì¤¿»öÎã
ľÀÜ¿¯³²¤ò¥µ¥Ý¡¼¥È¤¹¤ë¾Úµò¤¬ÉÔ½½Ê¬¤Î¤¿¤á¶µº¶¿¯³²¤¬ÈÝÄꤵ¤ì¤¿»öÎã
Åö¶È¼Ô¤ÎÄêµÁ¤Î¸í¤ê¤¬¤¢¤Ã¤¿¤È¤·¤ÆÃϺۤˤè¤ëÆõöÍ­¸ú¤È¤ÎȽ·è¤òʤ¤·¤¿»öÎã
EPO EPC2000¤¬Í½ÄêÄ̤ê12·î13Æü¤Ëȯ¸ú
¥¯¥í¥¢¥Á¥¢¤¬EPC¤Ë²ÃÌÁ¤Ø
3¡¡·î¡¡¹æ 449(3)
ÊÆ¡¡¹ñ Signal¡Ê¿®¹æ¡Ë¤ÏÊƹñÆõöË¡¡ø101¤Ëµ¬Äꤵ¤ì¤¿ÆõöÊݸî²Äǽ¤Ê¼çÂê¤Ë³ºÅö¤·¤Ê¤¤¤ÈȽÃǤ·¤¿»öÎã
ÆõöÄ£¤Ç¿³Íý¤µ¤ì¤Æ¤¤¤Ê¤¤¡ø101¤ÎË¡Äê¼çÂê¤Ë¤Ä¤¤¤ÆCAFC¤Ç¿³Íý¤¹¤ë¸¢¸Â¤¬¤¢¤ë¤È¤·¤¿»öÎã
Joint Infringement¤òΩ¾Ú¤¹¤ë¤¿¤á¤Ë¤ÏÈﵿ¿¯³²¼Ô¤¬Âè»°¼Ô¤ò´ÉÍý¡¢»Ø´ø¤·¤Æ¤¤¤ë¤³¤È¤Î¾ÚÌÀ¤¬É¬ÍפǤ¢¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
¿·µ¬À­µñÀä¤Îº¬µò¤È¤Ê¤ë¥¯¥ì¡¼¥àÍѸì¤Î²ò¼á¤¬ÉÔ¹çÍý¤Ê¤Û¤É¹­¤¤¤È¤·¤Æ¡¢µñÀäÍýͳ¤¬ÇË´þ¤µ¤ì¤¿»öÎã
¡Ècomprised of¡É¤¬¡Ècomprising¡É¤ÈƱ¤¸¥ª¡¼¥×¥ó¥¨¥ó¥É¤Î°Ü¹Ô¶ç¤Ç¤¢¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
ÆõöÄ£¤ËÂФ¹¤ëÅٽŤʤë¸í¤Ã¤¿Âбþ¤¬ÉÔ¸øÀµ¹Ô°Ù¤ÈȽÃǤµ¤ì¡¢Æõö15·ï¤¬¸¢Íø¹Ô»ÈÉÔǽ¤È¤µ¤ì¤¿»öÎã
¿¯³²¤¬Ç§¤á¤é¤ì¤ë¾ì¹ç¤Ç¤¢¤Ã¤Æ¤â¡¢¥é¥ó¥Ë¥ó¥°¥í¥¤¥ä¥ë¥Æ¥£ÎÁΨ¤Î»»Äê¤Ë¹çÍýŪ¤Êº¬µò¤¬¤Ê¤¤¤È¤·¤Æº¹Ìᤷ¤È¤Ê¤Ã¤¿»öÎã
ÆÈÀêŪ¼Â»Ü¸¢¼Ô¤ÎñÆÈÁʾÙŬ³Ê¤Ë¤Ä¤¤¤ÆȽÃǤ·¤¿»öÎã
¼«ÌÀÀ­¤ÎȽÃǤˤª¤¤¤Æ¡¢È¯ÌÀ¤È¤Ï²ÝÂ꤬°Û¤Ê¤ëʸ¸¥¤Ç¤â½ÅÍפÊʸ¸¥¤È¤·¤ÆºÎÍѤǤ­¤ë¤È¤µ¤ì¤¿»öÎã
EPO EPO°ÛµÄÉô¤¬Amazon.com¤Î¥®¥Õ¥È¥ª¡¼¥À¡¼Æõö¤ò¼è¾Ã
²¤½£ÆõöÄ£¤Ë¤è¤ë´Ú¹ñÆõöÅù¤Î±ÑʸËÝÌõ¶È̳¤Î³«»Ï
Âæ¡¡ÏÑ ³°¹ñ½Ð´ê¿Í¤Ë¤è¤ëÆõö¡¢°Õ¾¢¤ÎµñÀäÍýͳ¤ËÂФ¹¤ë±þÅú´ü´Ö¤ò60Æü´Ö¤«¤é90Æü´Ö¤ËÊѹ¹
4¡¡·î¡¡¹æ 559(4)
ÊÆ¡¡¹ñ ÆõöÁʾ٤ÇÇÔÁʤ·¤¿¾ì¹ç¡¢ºÇ¹â1²¯2,000Ëü¥É¥ë¤Þ¤Ç¤ò»Ùʧ¤¦¤È¸øɽ¤·¤¿»öÎã
´þµÑ¤µ¤ì¤¿Áʾ٤ˤª¤±¤ëÁʾٻ²²Ã¤Ï¡¢¸å¤ÎÁʾ٤ˤª¤¤¤Æ·ûË¡½¤ÀµÂè11¾ò¤Î¼ç¸¢ÌÈÀÕ¤ÎÊü´þ¤Ë³ºÅö¤·¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
¥¯¥ì¡¼¥à²ò¼á¤ò¸í¤Ã¤¿¤È¤·¤Æ¡¢ITC¤Î·èÄ꤬ʤ¤µ¤ìº¹¤·Ìᤵ¤ì¤¿»öÎã
¸¢¸¶Ä´ºº¤ÎØèÂդϡ¢ÆõöË¡285¾ò¡ÊÊÛ¸î»ÎÈñÍѡˤβ¼¤Ç¤ÎÎ㳰Ū¤Ê»ö·ï¤ÎÍ×·ï¤òËþ¤¿¤µ¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
³°Éô¾Úµò¤ÏÌÀºÙ½ñ¤¬¤½¤ì¼«Âμ»ܲÄǽ¤Ç¤¢¤ë¤«Èݤ«¤òÌÀ¤é¤«¤Ë¤¹¤ë¤¿¤á¤Ë»ÈÍѤ¹¤ë¤³¤È¤¬¤Ç¤­¤ë¤È¤·¤Æ¼Â»Ü²ÄǽÍ×·ï°ãÈ¿¤¬¹ÎÄꤵ¤ì¡¢Æõö̵¸ú¤ÈȽÃǤµ¤ì¤¿»öÎã
¿ôÃÍÈϰϤòµ¬Äꤷ¤¿¥¯¥ì¡¼¥à¤ËÂФ·¤Æ¤â¶ÑÅùÏÀ¤ÎŬÍѤ¬Ç§¤á¤é¤ì¤¿»öÎã
¥Ñ¥Æ¥ó¥È¥Õ¥¡¥ß¥ê¡¼¤Î·Ñ³À­¤¬ÅÓÀڤ줿¤¿¤á¥Õ¥¡¥ß¥ê¡¼Ãæ¤ÎÀè¤Î½Ð´ê¤Ë´ð¤Å¤­¿·µ¬À­Ìµ¤·¤È¤µ¤ì¤¿»öÎã
¿³ºº·Ð²á¤Ë¤ª¤±¤ëȯÌÀ¼Ô¤ÎÄĽҤ¬¡Èreceiving means¡É¤ò¶¹¤¯²ò¼á¤µ¤»¤ë¤è¤¦¤ÊÆâÍƤǤ¢¤Ã¤¿¤¬¡¢¤½¤ÎÄĽҤ¬¡Èreceiving means¡É¤Î¸¢ÍøÈϰϤΰìÉô¤òÌÀ¤é¤«¤ËÊü´þ¤·¤¿¤È¤¹¤ë¤Ë¤Ï½½Ê¬¤Ç¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
¥¯¥ì¡¼¥àµ­ºÜ¤ÎÍѸì¤òÌÀºÙ½ñ¤È¿Þ¤ò¹Íθ¤·¤Æ¸ÂÄêŪ¤Ë²ò¼á¤·¤¿»öÎã
¥¤¥®¥ê¥¹ ¥í¥ó¥É¥ó¶¨Äê¡Ê¥í¥ó¥É¥ó¥¢¥°¥ê¡¼¥á¥ó¥È¡Ë¤Îȯ¸ú¤¬2008ǯ5·î1Æü¤È¤Ê¤ë¤³¤È¤ò²¤½£ÆõöÄ£¤¬È¯É½
Ãæ¡¡¹ñ 2007ǯ¤ÎǯÅÙ¸¡ºº¤Ë629¤ÎÀìÍøÂåÍý»ö̳½ê¤¬¹ç³Ê
5¡¡·î¡¡¹æ 691(5)
ÊÆ¡¡¹ñ Àè¹Ôµ»½Ñ¤¬°Õ¿Þ¤¹¤ëÌÜŪ¤ò²Ì¤¿¤¹¤è¤¦¤ËÆ°ºî¤·¤Ê¤¤¤È¤¹¤ë¾Úµò¤Ë´ð¤Å¤­¡¢Æõö̵¸ú¤ÎΩ¾Ú¤¬ÈÝÄꤵ¤ì¤¿»öÎã
ÃϺۤ¬Èï¹ð¤Î¥Õ¥í¡¼¥É¤Ë´ð¤Å¤¯Èï¹ðÆõö¤ò̵¸ú¤È¤¹¤ë·èÄê¤òµñ¤ó¤ÀÅÀ¤Ë¸í¤ê¤Ï¤Ê¤¤¤È¤µ¤ì¤¿»öÎã
PTO¤Î¥¤¥ó¥¿¡¼¥Õ¥§¥¢¥ì¥ó¥¹¤Ë´Ø¤¹¤ëµ¬Â§²ò¼á¤Ë¤ÏÌ·½â¤¬¤¢¤ê¸í¤ê¤Ç¤¢¤ë¤È¤µ¤ì¤¿»öÎã
ÌÀºÙ½ñ¤ÎÌÀ¼¨Åª¤ÊÄêµÁ¤Ë¤è¤ê¥¯¥ì¡¼¥àÈϰϤ¬¸ÂÄꤵ¤ì¤¿»öÎã
ÃϺۤΡÈdata reference¡É¤Ë´Ø¤¹¤ëÆõö¤Î²ò¼á¤ò¡ÖÌÀºÙ½ñ¤Îµ­ºÜ¤òÆõö¤ÎÈϰϤ«¤é½ü³°¤¹¤ë¸í¤Ã¤¿²ò¼á¡×¤Ç¤¢¤ë¤È¤·¤ÆÈÝǧ¤·¡¢È󿯳²¤Îά¼°È½·è¤òº¹¤·Ìᤷ¤¿»öÎã
ºÆ¿³ºº¤Ç¤Î¥¯¥ì¡¼¥à¤ÎÄɲäˤª¤¤¤Æ¤Ï¡¢Àè¹Ôµ»½Ñ¤È¤Îº¹°Û¤òÌÀÇò¤ËÄĽҤ¹¤ë¤³¤È¤ÏÍ׵ᤵ¤ì¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
¥Ç¥£¥¹¥«¥Ð¥ê¡¼¤Ë¤ª¤±¤ë¾ðÊ󳫼¨µÁ̳°ãÈ¿¤Î¤¿¤á¡¢Åö»ö¼Ô¤Ë²Ã¤¨¤Æ¡¢Ã´ÅöÊÛ¸î»Î¤Ë¤âÀ©ºÛ¤¬²Ý¤µ¤ì¤¿»öÎã
¥É¥¤¥Ä Æõö¿³ºº¥Ï¥¤¥¦¥§¥¤¤Î»î¹Ô¤¬²¤½£¤Ç³ÈÂç
¥³¥½¥Ü ¥³¥½¥ÜÆõöÄ£³«Ä£
6¡¡·î¡¡¹æ 823(6)
ÊÆ¡¡¹ñ ½Ð´êÁ°¤ÎȯÌÀ¤Î¸ø³«¤¬35 U.S.C.¡ø102¡Êb¡Ë¤Ë³ºÅö¤¹¤ë¤«Èݤ«¤¬ÁèÅÀ¤È¤Ê¤Ã¤¿»öÎã
¡ÈComprising¡É¤ÇƳ¤«¤ì¤ë¥¯¥ì¡¼¥à¤Ë¤ª¤±¤ëÉÔÄê´§»ì¡ÈA¡É¤Þ¤¿¤Ï¡ÈAn¡É¤Ï¡ÈOne or More¡É¤ò°ÕÌ£¤¹¤ë¤È¤µ¤ì¤¿»öÎã
¿¯³²Áʾ٤ˤª¤¤¤Æ¿·µ¬À­¤Ë´Ø¤¹¤ë¿·¤·¤¤¸øȽÍ׵᤬ǧ¤á¤é¤ì¤¿¤¬°ÍÁ³¤È¤·¤Æ¿¯³²¤ÈǧÄꤵ¤ì¤¿»öÎã
Áʾ٤ˤª¤¤¤Æ¿³µÄ¤ÎÂоݤ«¤é¼è¤ê²¼¤²¤é¤ì¤¿Æõö¤Ë´Ø¤·¤Æ¤â¡¢ºÛȽ½ê¤ÏÉÔ¸øÀµ¹Ô°Ù¤Ë´ð¤Å¤­¸¢Íø¹Ô»ÈÉÔǽ¤È¤¹¤ëºÛȽ¸¢¤¬¤¢¤ë¤È¤·¤¿»öÎã
°ìÉô¤ÎÀÁµá¹à¤Ë¤Ä¤¤¤ÆÃϺۤˤè¤ë¿¯³²Ç§Äê¤ò´þµÑ¤¹¤ë°ìÊý¡¢Çå½þ³Û¤Ë¤Ä¤¤¤Æ¤ÏÃϺۤÎǧÄê¤ò»Ù»ý¤·¤¿»öÎã
ÀÁµá¤ÎÈÏ°ÏÁ´¤Æ¤Ë¤ª¤¤¤Æ¼Â»Ü²ÄǽÍ×·ï¤òËþ¤¿¤µ¤Ê¤«¤Ã¤¿¤¿¤áÆõö̵¸ú¤ÈȽÃǤ·¤¿»öÎã
È󿯳²À½ÉʤÎÈÎÇä¤Ë´ð¤Å¤¯°ï¼ºÍø±×¤òǧ¤á¤¿ÃϺÛȽÃǤ¬»Ù»ý¤µ¤ì¤¿»öÎã
Æõö¤µ¤ì¤¿°äÅÁ»Ò¤ò»ý¤Ä¼ï¤ò¸µ¤Ë¼ý³Ï¤µ¤ì¤¿¼ï¤ò¿¢¤¨¤ë¹Ô°Ù¤¬Æõö¤ò¿¯³²¤¹¤ë¤È¤·¤ÆÃϺۤÎȽ·è¤¬»Ù»ý¤µ¤ì¤¿»öÎã
¥¯¥ì¡¼¥àÍѸì¤Î²ò¼á¤¬Áè¤ï¤ì¤¿·ë²Ì¡¢Èﵿ¿¯³²ÉʤÎÈ󿯳²¤¬Ç§Äꤵ¤ì¤¿»öÎã
EWHC ºÛȽ½ê¤¬µ»½Ñɸ½àµ¬³Ê¤Ë´ØÏ¢¤¹¤ëÆõö¤Îɬ¿ÜÀ­¤òȽÃǤ·¤¿·ï
7¡¡·î¡¡¹æ 995(7)
ÊÆ¡¡¹ñ ¿³ºº·Ð²á¶ØÈ¿¸À¤¬Å¬ÍѤµ¤ì¤º¡¢¶ÑÅù¤¬Ç§¤á¤é¤ì¤¿»öÎã
Æõö¸¢¤Î¸Î°Õ¿¯³²¤ÎǧÄê¤Ë´Ø¤¹¤ëCAFC¤Î¿·´ð½à¤Ë¤Ä¤¤¤ÆºÆ¹Í¤òµá¤á¤ë¾å¹ðÀÁµá¤òºÇ¹âºÛ¤¬ÉÔ¼õÍý¤È¤·¤¿»öÎã
ÆâÉô¾Úµò¤Ë´ð¤Å¤­¥¯¥ì¡¼¥à¤ò¸ÂÄê²ò¼á¤·¤¿»öÎã
»îºîÉʤÎÈÎÇ俽½Ð¤¬¤¢¤Ã¤¿¤È¤ÎÍýͳ¤Ç102¾ò¡Êb¡Ë¤Î¡Èon-sale bar¡É¤Ë¤è¤êÂоݥ¯¥ì¡¼¥à¤¬Ìµ¸ú¤Ç¤¢¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
Æõö¸¢¼Ô¤¬¥é¥¤¥»¥ó¥¹Àïά¤Î°ì´Ä¤È¤·¤Æ¡¢ÀѶËŪ¤ËÁʾ٤ò¹Ô¤¦¤³¤È¤ò¸ø½°¤Ë¼¨¤¹¤³¤È¤Ï¡¢Èﵿ¿¯³²¼Ô¤È¤Î´Ö¤Ë¡È¸½¼Â¤ÎʶÁè¡É¤¬¤¢¤ë¤â¤Î¤È¤·¤Æ³ÎǧȽ·èË¡¤Ë¤ª¤±¤ë´É³í¸¢¤ÎÍ×·ï¤òËþ¤¿¤¹¤È¤·¤¿»öÎã
CAFC¹µÁʸå¤ÎÆõöË¡271¡Êf¡Ë¾ò¤Ë´Ø¤¹¤ëºÇ¹âºÛȽ·è¤Î±Æ¶Á¤Ë¤è¤ë¸«Ä¾¤·¤òµá¤áÃϺۤ˺¹¤·Ìᤵ¤ì¤¿»öÎã
¼«ÌÀ·¿Æó½ÅÆõö¤Î¥»¡¼¥Õ¥Ï¡¼¥Ð¡¼¾ò¹à¤Ç¤¢¤ë121¾ò¤ÏCIP½Ð´ê¤Ë¤ÏŬÍѤµ¤ì¤Ê¤¤¤ÈȽÃǤ·¤¿»öÎã
¸ÛÍÑ·ÀÌó¤Ë¤ª¤±¤ëȯÌÀ¤ÎÄêµÁ¤¬Û£Ëæ¤Ç¤¢¤Ã¤¿¾ì¹ç¤Ë¡¢¤¢¤ëȯÌÀ¤¬¸ÛÍÑ·ÀÌó¤ÎÈϰϤ˴ޤޤì¤ë¤«Èݤ«¤Ï²ñ¼Ò¤Îǧ¼±¤ÎÄøÅ٤ˤè¤êȽÃǤµ¤ì¤ë¤È¤µ¤ì¤¿»öÎã
²¾º¹»ß¤áÌ¿Îá¤ÏÆõö¤ÎÍ­¸úÀ­¤Ë¤Ä¤¤¤Æµ¿Ìä¤òÄ󵯤¹¤ë¤³¤È¤ÇÇË´þ¤µ¤ì¤ë¤È¤·¤¿»öÎã
EPO ¸ýƬ¿³ÍýÃ椪¤è¤Ó¤½¤ÎľÁ°¤Ç¤Î¿·¤¿¤ÊÀÁµáÅù¤Î²ÄÈݤˤĤ¤¤ÆȽÃǤ·¤¿EPO¿³·è¡ÊT 0450/03¡¡¿³·èÆü2008.2.12¡Ë
EPO¡ÝUSPTO¿³ºº¥Ï¥¤¥¦¥§¥¤¤Î»î¹Ô
¥¤¥ó¥É ¥¤¥ó¥ÉÆõö¿³ºº¥Þ¥Ë¥å¥¢¥ë¡Ê°Æ¡Ë¤Î¸ø³«
8¡¡·î¡¡¹æ 1115(8)
ÊÆ¡¡¹ñ ¡ÈPortable Computer¡É¤Ë¤Ï¥é¥Ã¥×¥È¥Ã¥×¥³¥ó¥Ô¥å¡¼¥¿¤Ï´Þ¤Þ¤ì¤Ê¤¤¤È¸ÂÄê²ò¼á¤µ¤ì¤¿»öÎã
Means-plus-function¤Ë¤è¤êÆÃÄꤵ¤ì¤ë¥³¥ó¥Ô¥å¡¼¥¿¡¼¤òÍѤ¤¤¿È¯ÌÀ¤Ï¡¢ÌÀºÙ½ñ¤Ë¤ª¤¤¤Æ¤½¤Î¶ñÂÎŪ¤Ê¥¢¥ë¥´¥ê¥º¥à¤Ë¤è¤ê¥µ¥Ý¡¼¥È¤µ¤ì¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¤È¤µ¤ì¤¿»öÎã
KSRºÇ¹âºÛȽ·è¤Î¼«ÌÀÀ­È½ÃǤ˴ð¤Å¤­¼«ÌÀ¤ÈȽ¼¨¤µ¤ì¤¿»öÎã
¹³¤±¤¤¤ì¤óÌô¤ò¥¯¥ì¡¼¥à¤¹¤ëÆõö¤¬Ìµ¸ú¤Ç¤Ï¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
USPTO¤¬¹ð¼¨¤·¤¿·Ñ³½Ð´ê¤Î²ó¿ôÀ©¸ÂÅù¤Ë´Ø¤¹¤ëµ¬Â§²þÀµ¤Ï̵¸ú¤Ç¤¢¤ë¤È¤·¤¿È½·è
¥Ñ¥¤¥×¥é¥¤¥ó¡¦¥×¥í¥»¥Ã¥µ¡¼¤Ë´Ø¤¹¤ë¥¯¥ì¡¼¥à¤ÎÉÔÌÀÎƤµ¤òÈÝÄꤷ¤¿»öÎã
¥¯¥ì¡¼¥àÃæ¤ÎÍѸì¡Öonly if¡×¤Ï°ìÈÌŪ¤Ê°ÕÌ£¤ò»ý¤Äʸ¸À¤Ç¤¢¤ë¤¬¡¢¤½¤ÎÍѸì¤Î¥¯¥ì¡¼¥à²ò¼á¤¬Í׵ᤵ¤ì¤¿»öÎã
Æõö¸¢¼Ô¤«¤éÈﵿ¿¯³²¼Ô¤Î¸ÜµÒ¤Ø¤Î¿¯³²·Ù¹ð¥ì¥¿¡¼Á÷Éդκ¹»ß¤á¤¬Ç§¤á¤é¤ì¤Ê¤«¤Ã¤¿»öÎã
USPTO¤¬Í¥À踢¤Ë¤Ä¤¤¤ÆȽÃǤ·¤Æ¤¤¤Ê¤¤¾ì¹ç¡¢¥¯¥ì¡¼¥à¤¬Àè¤Î½Ð´ê¤Ë´ð¤Å¤¯Í¥À踢¤òµý¼õ¤¹¤ë¤³¤È¤ÎΩ¾ÚÀÕǤ¤ÏÆõö¸¢¼Ô¤¬É餦¤È¤µ¤ì¤¿»öÎã
EPO ²¤½£ÆõöÄ£¤Î¼ê¿ôÎÁ²þÄê¤Ë¤Ä¤¤¤Æ¡Ê2008ǯ4·î1Æü»Ü¹Ô¡¢2009ǯ4·î1Æü»Ü¹Ô¡Ë
ÃÎŪºâ»º¸¢¤Î¼¹¹Ô¤Ë´Ø¤¹¤ë»ØÎáDirective 2004/48¤Î¥É¥¤¥Ä¤Ç¤ÎÍú¹Ô¾õ¶·
Ãæ¡¡¹ñ ³¤³°´Ø·¸¤ÎÃÎŪºâ»º¸¢Áʾ٤ËȽ·è
¡Ö¹ñ²ÈÃÎŪºâ»º¸¢Àïά¹ËÍספθøɽ
9¡¡·î¡¡¹æ 1237(9)
ÊÆ¡¡¹ñ Æõö¥é¥¤¥»¥ó¥¹¤ÎÃçºÛ¾ò¹à¤Ï·ÀÌó¤Ë½ð̾¤·¤Æ¤¤¤Ê¤¤¼Ô¤ò¹´Â«¤·¤Ê¤¤¤ÈȽÃǤ·¤¿»öÎã
Àè¹Ôµ»½Ñ¤È¥¤¹æʪ·ï¤È¤¬Æ±°ì¤Ç¤¢¤ë¤È¤Î¾ÚÌÀ¤À¤±¤Ç¤ÏÆõöȯÌÀ¤Ï¿·µ¬À­¤¬¤Ê¤¤¤ÈΩ¾Ú¤·¤¿¤³¤È¤Ë¤Ï¤Ê¤é¤Ê¤¤
¥Æ¥­¥µ¥¹Åì¶èϢˮÃϺÛȽ·è¤¬¡¢°ìÉô»Ù»ý¡¢°ìÉô´þµÑ¤µ¤ì¡¢º¹Ìᤵ¤ì¤¿»öÎã
ÆÈΩ¥¯¥ì¡¼¥à¤ò¥­¥ã¥ó¥»¥ë¤·¡¢¤½¤Î½¾Â°¥¯¥ì¡¼¥à¤ÎÆâÍƤò¿·¤¿¤ÊÆÈΩ¥¯¥ì¡¼¥à¤Ë¤·¤¿ÊäÀµ¤¬¿³ºº·Ð²á¶ØÈ¿¸À¤Ë³ºÅö¤¹¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
ÃϺۤˤè¤ë¥¯¥ì¡¼¥àÍ×·ï¡Èready for mounting on said tooth¡É¤Î²ò¼á¤Ï¶¹¤¹¤®¤¿¤¬¡¢Àµ¤·¤¤¥¯¥ì¡¼¥à²ò¼á¤Ë¤è¤Ã¤Æ¤âÈ󿯳²¤Ç¤¢¤ë¤È¤·¤Æά¼°È½·è¤ò»Ù»ý¤·¤¿»öÎã
CAFC¤¬ITC¤ÇȽÃǤµ¤ì¤¿ÆõöÍ­¸úÀ­¤ä¹ñÆ⻺¶ÈÍ×·ï¤ò¸¡Æ¤¤¹¤ë¤³¤È¤Ê¤¯¡¢È󿯳²¤Î·èÄê¤Î¤ß¤Ë´ð¤Å¤­ITC¤Î·èÄê¤ò°Ý»ý¤·¤¿»öÎã
ÈﵿÉʤ¬Àè¹ÔÁʾ٤ÎÈﵿÉʤÈËܼÁŪƱ°ì¤Ç¤Ê¤±¤ì¤Ð´ûȽ»ö¹à¤È¤Ï¸À¤¨¤Ê¤¤¤ÈȽÃǤ·¤¿»öÎã
¥¯¥ì¡¼¥à¤Îʸ¸À¤¬ÆâÉô¾Úµò¤Ë¤è¤Ã¤Æ¸ÂÄêŪ¤Ë²ò¼á¤µ¤ì¤ë¤È¤·¤Æ¿¯³²¤¬Ç§¤á¤é¤ì¤Ê¤«¤Ã¤¿»öÎã
ÉÔÀµ¹Ô°ÙȽÃǤˤª¤¤¤ÆÀëÀÀ½ñ¤Ë¿³ºº´±¤òµ½¤¤¤¿¤È¿ä¬¤µ¤ì¤ëÆâÍƤ¬´Þ¤Þ¤ì¤Æ¤¤¤¿¾ì¹ç¤Ëµ½¤Þ¤ó¤Î°Õ¿Þ¤¬¤¢¤ë¤ÈǧÄꤵ¤ì¤¿»öÎã
EPO ¿¢Êª¤ÎÀ¸»ºÊýË¡¤Ë´Ø¤¹¤ëÆõöÀ­¤Ë¤Ä¤¤¤Æ¡¢³ÈÂ翳ȽÉô¤ËÉÕÂ÷¤µ¤ì¤¿»öÎã¡ÊG1/08¡Ë
¥¤¥®¥ê¥¹ ±Ñ¹ñÃÎŪºâ»ºÄ£¡¡»î¸³¸¦µæ¤ÎÎã³°¤Ë¤Ä¤¤¤Æ¤Î°Õ¸«Ê罸
´Ú¡¡¹ñ ´Ú¹ñÃÎŪºâ»º¶¨µÄ²ñ¡ÊKINPA¡Ë³èÆ°³«»Ï
Âæ¡¡ÏÑ Ãҷź⻺ˡ±¡¤¬7·î1ÆüÀµ¼°ÀßΩÆó¸µÀ©¤Ç¥¹¥¿¡¼¥È
10¡¡·î¡¡¹æ 1381(10)
ÊÆ¡¡¹ñ Æõö̵¸ú¤È¤Îά¼°È½·è¤òÈò¤±¤ë¤¿¤áÀè¹Ôµ»½Ñʸ¸¥¤Î³«¼¨ÆâÍƤËÈ¿ÏÀ¤·¤Ê¤«¤Ã¤¿Æõö¸¢Íø¼Ô¤Ï¡¢¤½¤ÎÁèÅÀ¤ò¹µÁʤˤª¤¤¤Æ½é¤á¤ÆÄ󼨤¹¤ë¤³¤È¤Ï½ÐÍ褺¡¢¤Þ¤¿¡¢¿³Íý¤òÃϺۤ˺¹Ì᤹¤Ù¤­¤Ç¤â¤Ê¤¤¤È¤µ¤ì¤¿»öÎã
Æõö¸¢¼Ô¤ÈÈ󿯳²³ÎǧÁʾ٤θ¶¹ð¤È¤Î´Ö¤Ë¡¢¡Ö½½Ê¬¤Ê¶ÛµÞÀ­µÚ¤Ó¸½¼ÂÀ­¡×¤òǧ¤á¡¢È󿯳²³ÎǧÁʾ٤ÎȽ·è¤ò²¼¤·¤¿»öÎã
½½Ê¬¤Ê¾Úµò³«¼¨¼ê³¤¬¹Ô¤Ê¤ï¤ì¤Æ¤¤¤Ê¤¤¾ì¹ç¤Ë¡¢¤½¤Î¼ê³¤òÍ׵᤹¤ëºÝ¤ÎÍýͳÅù¤¬ÁèÅÀ¤È¤Ê¤Ã¤¿»öÎã
ÊýË¡¤ª¤è¤Ó¥·¥¹¥Æ¥à¤ÎÆõö¤Ï¼Â¼ÁŪ¤Ë¼Â»Ü¤µ¤ì¤ëÀ½ÉʤÎÈÎÇä¤Ë¤è¤Ã¤Æ¾Ã¿Ô¤¹¤ë¤ÈȽÃǤ·¤¿»öÎã
Æõö¿¯³²¤Ë¤è¤ë»³²³Û¤ò°ï¼ºÍø±×¤Ë´ð¤¤¤Æ»»Äꤹ¤Ù¤­¤«¤¬Áè¤ï¤ì¤¿»öÎã
¥¯¥ì¡¼¥à¤Îʸ¸À¤¬¡Èpartially hidden¡É¤Ç¤¢¤Ã¤¿¤È¤­¡Ètotally hidden¡É¤Ï¥¯¥ì¡¼¥àÈϰϤ˴ޤޤì¤Ê¤¤¤ÈȽÃǤ·¤¿»öÎã
»ö·ï¤¬¡ÖÎ㳰Ū¡×¤Ç¤¢¤ë¤È¤·¤ÆÆõöË¡285¾ò¤òŬÍѤ¹¤ë¤¿¤á¤Ë¤Ï¡¢¡ÖÎ㳰Ū¡×¤ÈȽÃǤ·¤¿º¬µò¤òÌÀ¤é¤«¤Ë¤¹¤Ù¤­¤È¤·¤Æ¡¢¿³Íý¤òº¹¤·Ìᤷ¤¿»öÎã
°Ý»ýǯ¶âÉÔʧ¤¤¤Ë¤è¤ê¼º¸ú¤·¤¿Æõö¤ÎÉü³è¤¬µñÀ䤵¤ì¤¿»öÎã
ÉÔ¸øÀµ¹Ô°Ù¤Ë¤è¤ë¼èÆÀ¤·¤¿Æõö¤Ë¤è¤ë¸¢Íø¤Î¸¢Íø¹Ô»ÈÉÔǽ¤òǧ¤á¤¿»öÎã
EWHC EWHC¡Ê¥¤¥ó¥°¥é¥ó¥É¥¦¥§¡¼¥ë¥ºÃϺۡ¢¥¤¥®¥ê¥¹¡Ë¡Î2008¡ÏEWHC1422¡ÊPat¡Ë
EWHC¤¬Î©ÂΰÛÀ­ÂΤÎÆõöÀ­¤òȽÃǤ·¤¿»öÎã
EPO EPC2000¤Ë¤è¤êƳÆþ¤µ¤ì¤¿À©ÅÙ¤ÎÍøÍѾõ¶·¤ò²¤½£ÆõöÄ£¤¬È¯É½
11¡¡·î¡¡¹æ 1525(11)
ÊÆ¡¡¹ñ ¿³ººÃæ¤ÎÉÔÊ¿¹Õ¹Ô°Ù¤ª¤è¤ÓÉÔÉʹԤÊÁʾټ곤ˤè¤ê¡¢ÊÛ¸î»ÎÈñÍѤÎÊֺѤòǧ¤á¤¿ÃϺÛȽ·è¤¬»Ù»ý¤µ¤ì¤¿»öÎã
¥¯¥ì¡¼¥àÃæ¤ÎÄêµÁÄ̤ê¤Ë¸·³Ê¤Ëʸ¸À²ò¼á¤·È󿯳²¤ÈȽÃǤµ¤ì¤¿»öÎã
Í¥À迳ºº¿½ÀÁ¤ò¹Ô¤¦¾ì¹ç¡¢¿¯³²À½Éʤθºß¤ÎΩ¾Ú¤Ë¤Ä¤¤¤Æ¤Ï¼ÂºÝ¤ÎÀ½ÉʤÈÆõö¥¯¥ì¡¼¥à¤È¤ÎÈæ³Ó¤òÍפ·¤Ê¤¤¾ì¹ç¤¬¤¢¤ë
Claim Preclusion¤Ë¤è¤êÆõö¤Î̵¸úµÚ¤Ó¸¢Íø¹Ô»ÈÉÔ²Äǽ¤È¤·¤¿ÃϺۤÎȽÃǤ¬»Ù»ý¤µ¤ì¤¿»öÎã
¶¦Æ±¹Ô°Ù¤Ë¤è¤ëľÀÜ¿¯³²¤ÎÀ®Î©À­¤Ë¤Ä¤¤¤ÆÁè¤Ã¤¿»öÎã
ÃϺۤˤª¤±¤ë¥¯¥ì¡¼¥à²ò¼á¤¬ÉÔÌÀÎƤǤ¢¤Ã¤¿°Ù¤Ë¡¢ÃϺۤÎƱ°ÕȽ·è¤¬Ìµ¸ú¤Ç¤¢¤ë¤ÈȽÃǤµ¤ì¤¿»öÎã
ȯÌÀ¼ÔŬ³Ê¤Ë´Ø¤¹¤ëÄóÁʤÎÃ٤줬ØèÂդˤ¢¤¿¤ë¤È¤µ¤ì¤¿»öÎã
²½¹çʪ¤ÎȯÌÀ¤Ë¤ª¤¤¤ÆÈó¼«ÌÀÀ­¤¬Ç§¤á¤é¤ì¤¿»öÎã
¥¯¥ì¡¼¥àÃæ¤ÎÍѸì¤Î°ÕÌ£¤¬¿³ºº·Ð²á¤Ë¤è¤ê¸ÂÄê²ò¼á¤µ¤ì¡¢È󿯳²¤È¤µ¤ì¤¿»öÎã
EPO ʬ³ä½Ð´ê¤¬EPC76¾ò1¹à¤Ë°ãÈ¿¤¹¤ë¤È¤·¤Æ¼çÀÁµá¤òÇË´þ¤·¡¢Âå¤ï¤ê¤Ë¸ýƬ¿³ÍýÃæ¤ËÄɲä·¤¿Êä½õŪÀÁµá¤òµö²Ä¤·¤¿EPO¿³·è¡ÊT 0248/04¡¡¿³·èÆü2008.1.22¡Ë
Rule 89¤Ë´ð¤Å¤¯ÄûÀµ¤òǧ¤á¤Ê¤«¤Ã¤¿EPO¿³·è¡ÊT 1093/05¿³·èÆü2007.6.13¡Ë
Ãæ¡¡¹ñ Ãæ¹ñÀìÍøË¡²þÀµ°ÆÁð°ÆÁ´Ê¸¤ª¤è¤ÓÀâÌÀ¤Î¸ø³«
12¡¡·î¡¡¹æ 1633(12)
ÊÆ¡¡¹ñ ÉÔÀµ¹Ô°Ù¤Ë¤è¤ë¸¢Íø¹Ô»È¤ÎÀ©¸Â¤Ë¤Ä¤¤¤Æ¤Î»öÎã
FDAǧ²Ä¤Î¤¿¤á¤Î¥Ç¡¼¥¿¼ý½¸¤Î¤¿¤á¤ÎÁõÃ֤ˤÏ35 U.S.C¡ø271¡Êe¡Ë¡Ê1¡Ë¤Ë¤è¤ëÌÈÀÕ¤¬Å¬±þ¤µ¤ì¤Ê¤¤¤ÈȽÃǤµ¤ì¤¿»öÎã
Æõö¸¢¼Ô¤ÎÀѶËŪ¹Ô°Ù¤Ê¤·¤Ë¡¢¼ç´Ñ¤Ë´ð¤Å¤¯Â»³²¤Î¶²¤ì¤Î¤ß¤Ç¤Ï³ÎǧÁʾ٤¬Ç§¤á¤é¤ì¤Ê¤«¤Ã¤¿»öÎã
¶ÑÅùÏÀ¤ÎÇ濳°÷ȽÃǤò»Ù»ý¤·¡¢º¹»ßÀÁµá¤Î¿½Î©¤òÈÝǧ¤·¤¿»öÎã
Åö»ö¼Ô·ÏºÆ¿³ººÀ©Å٤˴ؤ¹¤ëË¡¤Î¤¢¤¤¤Þ¤¤¤ÊÍѸì¤Ë¤Ä¤¤¤ÆÆõöÄ£¤Î²ò¼á¤¬Å¬ÍѤµ¤ì¤ë¤ÈȽÃǤ·¤¿»öÎã
¹µÁÊÍѤÎÃϺۻö·ïµ­Ï¿¤Ëµ­Ï¿¤µ¤ì¤Æ¤¤¤Æ¤â¡¢Ë¡Î§ÌäÂê¤Ë´ØÏ¢¤·¤ÆÃϺۤËÄó½Ð¤µ¤ì¤¿¾Úµò¤Ç¤Ê¤±¤ì¤Ð¹Í褵¤ì¤Ê¤¤¤È¤·¤¿»öÎã
Î×¾²»î¸³¡Êclinical trials¡Ë¤Î¼Â»Ü¤Ï¸øÁ³»ÈÍÑ¡Êpublic use¡Ë¤È¤Ï¸À¤¨¤Ê¤¤¤È¤·¤¿»öÎã
UKHL UKHL¡§¡Î2008¡ÏUKHL49¡ÊUK House of Lords¡Ë¥¤¥®¥ê¥¹¾å±¡¤¬¼«ÌÀÀ­¤Ë¤Ä¤¤¤ÆȽÃǤ·¤¿»öÎã
EPO ¡ÚEU¶¥ÁèÎÏÍý»ö²ñ¡ÛÊñ³çŪ¤ÊÈ¿ÌÏÊïÉÊ¡¦È¿³¤Â±ÈǷײè¤Ë´Ø¤¹¤ë·èµÄ¤ò¹Ô¤¦¡£¡Ê¥Ö¥ê¥å¥Ã¥»¥ë¡¢2008ǯ9·î25Æü¡Ë

¡½ ¤ª¡¡¤·¡¡¤é¡¡¤» ¡½

ÊÇ¡¡¡¡¹æ
Ãæ¹ñ¤Ë¤ª¤±¤ëÃÏÍýŪɽ¼¨¤ÎÊݸî¤Ë´Ø¤¹¤ëˡΧÀ©ÅÙµÚ¤Ó´ØÏ¢¤¹¤ë¾õ¶· Ãæ¹ñ¹ñ²È¹©¾¦¹ÔÀ¯´ÉÍýÁí¶É¶ÉĹ
°Â¡¡ÀÄ¡¡¸×
285¡Ê2¡Ë
ÃÏ°èÊÌÉô²ñ¤Î³«ºÅͽÄêÆü¤Ë¤Ä¤¤¤Æ   557¡Ê4¡Ë

¶¨²ñÆâÉô´©¹Ô»ñÎÁ¡Ê2007¡Á2008ǯ¡Ë

»ñÎÁNo.¡¦»ñÎÁ̾¾Î¡¦¼¹É®¼Ô ´ØÏ¢µ­»ö¤Î
¡ÖÃκâ´ÉÍý¡×»ï
·ÇºÜ¥Ú¡¼¥¸
No.365
±Ä¶ÈÈëÌ©´ÉÍý¤Ë¤ª¤±¤ë¥¢¥ó¥±¡¼¥ÈÄ´ººÊó¹ð½ñ¡Ê´ÉÍý¼ÂÂÖ¤ÎʬÀÏÊó¹ð¡Ë
¡Ê¥Õ¥§¥¢¥È¥ì¡¼¥É°Ñ°÷²ñ¡Ë
No.366
¥Ù¥È¥Ê¥à¡¦¥¿¥¤¡¦¥Þ¥ì¡¼¥·¥¢Ë¬ÌäÂåɽÃÄÊó¹ð
¡Ê¥¢¥¸¥¢Àïά¥×¥í¥¸¥§¥¯¥È¡Ë
No.367
Ãæ¹ñˬÌäÂåɽÃÄÊó¹ð
¡Ê¥¢¥¸¥¢Àïά¥×¥í¥¸¥§¥¯¥È¡Ë
No.368
Âè7²óJIPAÃκ⥷¥ó¥Ý¥¸¥¦¥à³«ºÅÊó¹ð½ñ
¡ÊÂè7²óJIPAÃκ⥷¥ó¥Ý¥¸¥¦¥à¼Â¹Ô°Ñ°÷²ñ¡Ë
No.369
¥Ö¥é¥¸¥ë¤ÎÃÎŪºâ»ºÀ©ÅÙ
¡Ê¹ñºÝÂè1°Ñ°÷²ñ¡Ë
No.370
¥é¥¤¥»¥ó¥¹·ÀÌó¼Â̳¥Þ¥Ë¥å¥¢¥ë¡½·ÀÌó¾òʸÎãÉÕ¤­¡½
¡Ê¥é¥¤¥»¥ó¥¹Âè2°Ñ°÷²ñ¡Ë
No.371
´Ú¹ñ¤Ë¤ª¤±¤ëÆõö¸¢¼èÆÀ¾å¤Îα°ÕÅÀ¡Ê²þÄûÈÇ¡Ë
¡Ê¹ñºÝÂè3°Ñ°÷²ñ¡Ë
No.372
¥¨¥ó¥É¥æ¡¼¥¶¡¼¸þ¤±¤ÎÆõö¾ðÊ󸡺÷¶µ°é¤Ë¤Ä¤¤¤Æ¤Î¸¦µæ¤ÈÄó¸À¡ÊCD-ROMÈÇ¡Ë
¡ÊÃÎŪºâ»º¾ðÊ󸡺÷°Ñ°÷²ñ¡Ë
No.373
Ãæ¹ñ¤Ë¤ª¤±¤ëÆõö¸¢¼èÆÀ¾å¤Îα°ÕÅÀ¡Ê²þÄûÂè2ÈÇ¡Ë
¡Ê¹ñºÝÂè3°Ñ°÷²ñ¡Ë
TITLES IN ENGLISH FOR ARTICLES UNDER ASTERISKED(*) GENRES Vol. 58 (2008)

¡½ GREETINGS ¡½

p. No.
Annual Message Masahiro KOEZUKA,
Commissioner of JPO
1(1)
Annual Message Tamotsu NOMAKUCHI,
Chairman of JIPA
3(1)

¡½ GUEST COMMENTS ¡½

p. No.
For the Cultivation of an Innovative Mindt Michiei NAKAMURA 151(2)
Function of Intellectual Property in Product Development Makoto IGA 311(3)
Standardization and Intellectual Property Rights Kohei ONO 459(4)
Intellectual Property Strategy of Shiseido Co. Ltd Kazuo TOKUBO 569(5)
Intellectual Property Activities Contributing to Corporate
Management
Kazumi YASUZUMI 701(6)
A MOT Standpoint and Intellectual Property Rights Kosaku NAKANO 1005(8)
IP Aware Design and Manufacturing Masaharu ISHII 1127(9)
RIKEN¡Çs Baton Zone for Effective Technology Transfer Shigekazu SAITOU 1247(10)
Intellectual Property Management in the Service Industry Shuji MAEDA 1391(11)
IP Strategy of DOWA HOLDINGS Masaru NAMURA 1537(12)

¡½ ADDRESSES ¡½

¡ÊAT THE ANNUAL CONGRESS HELD ON MAY 30, 2008¡Ë

p. No.
Address by Tamotsu NOMAKUCHI, Chairman of the Japan Intellectual Property
Association¡ÊJIPA¡Ë
831(7)
Address by Naoki TOMINO, Vice Chairman of JIPA 833(7)
Address by Akira MATSUZAKI, Vice Chairman of JIPA 834(7)
Association¡Çs 2007 Business Report by Taisuke KATO,
Former President of JIPA
835(7)
Association¡Çs Management Policy by Hirohiko USUI, President of JIPA 838(7)
Address of Gratitude from Isamu SHIMURA, on Behalf of the Recipients of
JIPA¡Çs Annual Citations
845(7)

¡½ SPECIAL EDITION¡§How to Respond to IP RISK ¡½

p. No.
Planning the Special Edition Publication and
Public Affairs Committee
313¡Ê3¡Ë

¡½ SPECIAL ARTICLES ¡½

p. No.
Patent Litigation Strategies Japanese Companies Should Take
in Europe
Eiji KATAYAMA,
Masahiro OTSUKI,
Makoto HATTORI
315¡Ê3¡Ë
Changes in U.S. Patent System and Operation,
and Directions for Countermeasures
Ken-ichi HATTORI 339¡Ê3¡Ë
Measures to Prevent Technology Leaks During
International Technology Transfers
¡ÝInstitutional issues to consider when transferring technology to China¡Ý
Fair Trade Committee 359¡Ê3¡Ë
Reviewing Patent Risk in M&A Cases Based on
¡ÈEssential Patent Portfolio Theory¡É
Masahiro SAMEJIMA,
Yohei IWASAKI
375¡Ê3¡Ë
Relationship Between Assignment of Component/Licensing of
Component Patent and Enforcement of Final Product Patent
¡ÝAnalysis of scope of exhaustion and implied license¡Ý
Takamitsu SHIGETOMI 387¡Ê3¡Ë
Copyright Issues in Services Providing User Access to
Digital Content
¡ÝWho is the infringer?¡Ý
Digital Contents Committee 399¡Ê3¡Ë

¡½ ARTICLES ¡½

p. No.
Significance of KSR v. Teleflex in Historical Development of Nonobviousness Standard Under US Patent Law Toshiko TAKENAKA 5¡Ê1¡Ë
Metaverse Culture and Intellectual Property Haruo HAMADA 21¡Ê1¡Ë
Discussion of Promotion and Inhibition of Innovation by Software Patents
¡ÝIn particular, from the viewpoint of protecting licensees¡Ý
Mitsuyoshi HIRATSUKA 31¡Ê1¡Ë
New Comprehensive Type Registration System Established by Special Measures for Industrial Revitalization and Related Issues Concerning License Transactions Shunji MATSUDA 41¡Ê1¡Ë
Summary of EPC2000 and Introduction of Important EPO Appeal Board Decisions The First Subcommittee,
The Second International
Affairs CommitteeI
55¡Ê1¡Ë
What Must Be Done at the Beginning of US Litigation
¡ÝUtilizing¡ÈLitigation Hold¡Éto ensure preservation of evidence and making maximum use of attorney-client privilege and work product doctrine¡Ý
Taro ISSHIKI 153¡Ê2¡Ë
Current Design Protection Status for Companies and Design Filing Strategies Hironori ONDA 163¡Ê2¡Ë
Issue of IP Human-Resources and Expectations for In-House Patent Attorneys Hajime INOUE 181¡Ê2¡Ë
Future Prospect of Examination Standards for Three-dimensional Trademarks
¡ÝIn view of the Mini-Maglight decision¡Ý
Ayako MITSUNO 191¡Ê2¡Ë
Survey of JIPA Members¡ÇAnswers to Questionnaire on Patent Prosecution Highway The First Subcommittee,
The First Patent Committee
201¡Ê2¡Ë
Trial Implementation of Industry-University Collaboration for Creating Effective Scheme for Practical Use of IP
¡ÝSpeedy commercialization of chemical reagents by using ¡ÈCollaborative Research Projects¡É¡Ý
Noriyuki ITOU,
Hisashi YAMAUCHI,
Katsuhiko FURUKAWA
461¡Ê4¡Ë
Invalidity and Public Domain Technology Defenses in Infringement Actions Tomohiko MAKINO 471¡Ê4¡Ë
Prior Use Right and Preparation of Proof Thereof Eiichiro KUBOTA 483¡Ê4¡Ë
Relationship Between Merchandising Right and Intellectual Property Rights
¡ÝProblems and countermeasures¡Ý
Riichi USHIKI 491¡Ê4¡Ë
Ideal Intellectual Property Activities that Effectively Contribute to Corporate Management The Second Subcommittee,
The First Intellectual Property
Management Committee
503¡Ê4¡Ë
Protection of the Shape of Goods Under the Japanese Unfair Competition Prevention Law Mikio KAWASE 571¡Ê5¡Ë
Points to Consider Regarding Chinese Trademark Related Systems for Countermeasures Against Imitations Takahiro MIYAHARA 591¡Ê5¡Ë
Study of Employee Invention Remuneration Relating to Pharmaceuticals The Pharmaceutical Industry Working Group for Employees¡ÇInventions,
Edited by Minoru TAKEDA
603¡Ê5¡Ë
Problems Related to Network Transmission Rights Under Chinese Copyright law HU Yunhong 617¡Ê5¡Ë
Post-KSR ANDA Litigation in the United States:
¡ÝDevelopments in the Law of Chemical Obviousness Relevant to Pharmaceutical Compounds and Compositions¡Ý
Adam P. SAMANSKY,
Jun UMEMURO
703¡Ê6¡Ë
Study of Problems Regarding IP¡ÈInnovation¡ÉProcess
¡ÝIP department role and involvement in improving invention and specification¡Ý
The Second Subcommittee,
The First Patent Committee
711¡Ê6¡Ë
Trends in US Court Decisions and Practical Considerations Regarding Tying
¡ÝFocusing on patent-related cases¡Ý
The First International
Affairs Committee
729¡Ê6¡Ë
Three Ground Rules for Senior Managers in IP Departments:
Successful Mentoring and Coaching for IP Staff Individual Development,
¡Ý¡ÈYou May be Making Mistakes¡É¡Ý
The Third Subcommittee,
The First Intellectual Property
Management Committee
741¡Ê6¡Ë
Inequitable Conduct Defense and Requirements for Proving Walker Process Fraud Claim in the US The First International
Affairs Committee
847¡Ê7¡Ë
Points to Consider in Obtaining Patents in Vietnam The Third International
Affairs Committee
859¡Ê7¡Ë
Comparative Study of Trilateral Patent Prosecution Practice for Antibody Patents The Second Subcommittee,
Biotechnology Committee
873¡Ê7¡Ë
Response to Technical Outflow by Group Control of Know-How and Patents The Fourth Subcommittee,
The First Intellectual Property
Management Committee
899¡Ê7¡Ë
Comparison of Laws Related to Indication of Goods or Business Fair Trade Committee 913¡Ê7¡Ë
Comparison of Business Model Patents with Bioinformatics Patents in Japan Akihiko OKUNO 1007¡Ê8¡Ë
Consideration of Determinations in Japan, the U.S., Europe, China and Korea Regarding Specification Description Requirements The Third Subcommittee,
The First Patent Committee
1019¡Ê8¡Ë
Trends in the United States after the KSR Obviousness Determination The First International
Affairs Committee
1037¡Ê8¡Ë
Amendment in Opposition Proceedings and Admissibility of Appellant in the EPO The First Subcommittee,
The Second International
Affairs Committee
1049¡Ê8¡Ë
Management of Taxation on Global Intellectual Property Transactions
¡ÝOverview of taxation on IP transactions and management of transfer pricing taxation for IP transactions¡Ý
The Third Subcommittee,
The Second
Intellectual Property
Management Committee
1057¡Ê8¡Ë
Studies on Licensor¡Çs Liabilities in Know-How License Agreements The First Subcommittee,
The Second License Committee
1073¡Ê8¡Ë
Amendment in Chinese Patent System and Points of Practice to Consider He Xiaoping 1129¡Ê9¡Ë
Study of Problems Obstructing Public Examination Opportunities
¡ÝReviewing issues related to granting pre-published patent applications¡Ý
The Sixth Subcommittee,
The First Patent
Committee
1139¡Ê9¡Ë
Study of Invalidity Defenses in Patent Infringement Lawsuits
¡ÝFocus on illegal divisionals and amendments¡Ý
The First Subcommittee,
The Second Patent Committee
1147¡Ê9¡Ë
Recent Trends in Induced Infringement Decisions in the US and Practical Considerations Thereof
¡ÝFocus on en banc decision in DSU case¡Ý
The First International
Affairs Committee
1161¡Ê9¡Ë
Examination of Pharmaceutical Use Invention Characterized by Disease Treatment and Trilateral Comparison¡Ê1¡Ë The First Subcommittee,
Biotechnology Committee
1171¡Ê9¡Ë
Trends Surrounding International Norm Setting for IP Security Interests and Future Perspectives
¡ÝWorking Group VI of UNCITRAL¡Ý
Takeshi HISHINUMA 1249¡Ê10¡Ë
Methods for Centralized Management of IP in Group Companies
¡ÝUse of IP trusts¡Ý
Naoki KYOMOTO,
Satoshi YOSHI
1257¡Ê10¡Ë
Protection of Shapes as 3D Trademarks in Japan¡ÊNo.1¡Ë
¡ÝCoca-Cola 3D Trademarks case¡Ý
Yoshiyuki TAMURA,
LIU Hsiao-Chien
1267¡Ê10¡Ë
Study of Standards for Determining Addition of New Matter The Fourth Subcommittee,
The First Patent Committee
1279¡Ê10¡Ë
Points for Avoiding Business Reputation Damage Charges When Warning Competitor¡Çs Customer About Patent Infringement The Sixth Subcommittee,
The Second Patent Committee
1299¡Ê10¡Ë
Examination of Pharmaceutical Use Invention Characterized by Disease Treatment and Trilateral Comparison¡ÊNo.2¡Ë The First Subcommittee,
Biotechnology Committee
1311¡Ê10¡Ë
Consideration of Group IP Management for Maximization of Group Corporate Value
¡ÝIP organization, function and methods for selecting concentration or dispersal of IP rights¡Ý
The First Subcommittee,
The Second Intellectual Property
Management Committee
1327¡Ê10¡Ë
Managing Non-Disclosure Agreements in Accordance with Business Strategies The Second Subcommittee,
The First License Committee
1339¡Ê10¡Ë
Protection of Shapes as 3D Trademarks in Japan¡ÊNo.2¡Ë
¡ÝCoca-Cola 3D Trademark case¡Ý
Yoshiyuki TAMURA,
LIU Hsiao-Chien
1393¡Ê11¡Ë
Study of the Concept of¡ÈAssignment¡ÉUnder Japanese Patent Law Tomohiko MAKINO 1405¡Ê11¡Ë
Fund Raising by Intellectual Property Tetsuya HABU 1421¡Ê11¡Ë
Visualization Method for Obtaining Valuable Patents
¡ÝIP strategy in the electronic and software fields¡Ý
Akihiro RYUKA 1435¡Ê11¡Ë
Study of Examination Process As Seen From the Examination Guidelines
¡ÝSupport and enablement requirements¡Ý
The Sixth Subcommittee,
The First Patent Committee
1455¡Ê11¡Ë
Relationship Between Correction Trials/Requests for Correction and Patent Infringement Litigation The Fifth Subcommittee,
The Second Patent Committee
1471¡Ê11¡Ë
Intellectual Property Policies Vitally Needed Now in Corporate IP Management
¡ÝFive institutional actions proposed by business¡Ý
The Second Subcommittee,
The Second Intellectual Property Management Committee
1487¡Ê11¡Ë
US Patent Prosecution Management, Pitfalls of Time Charge System and Considerations for Overseas Clients Tetsu YOSHIDA,
David E. ROBINSON
1539¡Ê12¡Ë
Considerations Regarding Prior Art Searches The Fifth Subcommittee,
The First Patent Committee
1555¡Ê12¡Ë
Claim Interpretation in Patent Infringement Litigation after Supreme Court Decision in Texas Instruments vs. Fujitsu Case
¡ÝEffect of patent validation on infringement judgment¡Ý
The Fourth Subcommittee,
The Second Patent Committee
1567¡Ê12¡Ë

¡½ CASE LAW AND PRACTICE ¡½

p. No.
No.348
Copyright Notice in Peter Rabbit Case
Hitoshi SAKATA 67¡Ê1¡Ë
No.349
Export of Key Components for Manufacturing Abroad
Tetsu IWATSUBO 211¡Ê2¡Ë
No.350
Case Regarding Contract Enforceability
Tsukasa MATSUMOTO 519¡Ê4¡Ë
No.351
Study and Review of Designated Goods Based on Actual State of Transaction
Miho HIROTA 625¡Ê5¡Ë
No.352
Copying Family Portrait Photo in Nonfiction for Identifying the Portrayed
Person Held Liable for Infringement
Ryoko ISEKI 757¡Ê6¡Ë
No.353
Applications for Patent Term Extensions
¡ÝCan Patent Term Extension Be Granted Based on Approval to Manufacture¡Ý
Eiji SAEGUSA 923¡Ê7¡Ë
No.354
Patented Products and Specifications for Which Exhaustion Doctrine Became a Problem
Giro KURAUCHI 1087¡Ê8¡Ë
No.355
Patent Right Restoration Under Patent Law Article 112-2¡Ê1¡Ë
¡Ý¡Èreasons outside patentees control¡É¡Ý
Yoko WAKAMATSU 1189¡Ê9¡Ë
No.356
Originality of a Partial Design
Masayuki HABU 1349¡Ê10¡Ë
No.357
Duty of Care Implicit in Avoiding Copyright Infringement When Consigning Production of Advertising Materials
Hajime MORIWAKI 1503¡Ê11¡Ë
No.358
Content Required for Determining Trademark Validity under Japanese Trademark Law Section 3¡Ê2¡Ë
¡ÝSuit against an Appeal Decision concerning trademark ¡ÈAJ¡É¡Ý
Takashi ONODERA 1581¡Ê12¡Ë

¡½ CASE LAW AND STUDY ¡½

p. No.
No.322
Copyright Contract Concerning Cinematographic Work
Osamu WATANABE 75¡Ê1¡Ë
No.323
Validity of a Manufacturing License Agreement Including a 10 Year Non-Compete Provision and Damages for Breach Thereof
Yusuke SATO 225¡Ê2¡Ë
No.324
Three-Dimensional Trademark Registration Requirements
¡ÝMAGLITE 3D Trademark case¡Ý
Ryu KOJIMA 529¡Ê4¡Ë
No.325
Use of Copyrighted Movie Material in Pachinko Game Machines, etc.
Riichi USHIKI 637¡Ê5¡Ë
No.326
First Case of Protective Order in IP litigation
Shunji MIYAMA 767¡Ê6¡Ë
No.327
Case Finding Patent Infringement For Importing and Reselling Recycled Patented Products
Hisayosi YOKOYAMA 935¡Ê7¡Ë
No.328
Case Holding that Japan Not Obligated to Protect Cinematographic Works by North Korean Nationals
Shigeki CHAEN 1099¡Ê8¡Ë
No.329
Term of Protection for Film Published in 1953 in the Name of a Corporation
Masami ASHIDATE 1199¡Ê9¡Ë
No.330
Distinctiveness and Secondary Meaning of Three Dimensional Trademark for a Goods¡ÇPackage
¡ÝThe Coca Cola bottling case¡Ý
Mikio KAWASE 1593¡Ê12¡Ë

¡½ PUBLICATIONS AND REPORTS ¡½

p. No.
Recent Judicial Precedent Related to Unfair Competition Prevention Act Fair Trade Committee 89¡Ê1¡Ë
Development of Training Courses for¡ÈLeaders for IP Change¡É and¡ÈIP Strategy Staff¡É Human Resource
Development Committee
95¡Ê1¡Ë
Symbol Marks for Indicating Trademarks and Creative Works
¡ÝBetter late than never series¡Ê3¡Ë¡Ý
Tomoyasu AMINO 105¡Ê1¡Ë
Indirect Infringement
¡ÝBetter late than never series¡Ê4¡Ë¡Ý
Tadashige ITOH 233¡Ê2¡Ë
Means Plus Function Claim
¡ÝBetter late than never series¡Ê5¡Ë¡Ý
Sadakazu IGETA 539¡Ê4¡Ë
The New Unfair Competition Prevention Law Dr. Frauke Henning-Bodewig
Translated by
German Intellectual
Property Law Seminar
649¡Ê5¡Ë
¡ÈQuotations¡É Under Japanese Copyright Law
¡ÝBetter late than never series¡Ê6¡Ë¡Ý
Digital Contents Committee 667¡Ê5¡Ë
Key Words for University IP Activities
¡Ý¡ÈFrom quantity to quality¡É, ¡ÈDiversification¡É, ¡ÈFusion¡É¡Ý
Yasushi IRIE 775¡Ê6¡Ë
EU Legislation Against Counterfeiting and Piracy in the Single Market¡ÊNo.1¡Ë
¡ÝFocusing on COUNCIL REGULATION¡ÊEC¡Ë
No 1383/2003¡Ý
The Second Subcommittee,
The Second International
Affairs Committee
789¡Ê6¡Ë
Overview of Peculiar Design Law System
¡ÝBetter late than never series¡Ê7¡Ë¡Ý
Takako IMAI 801¡Ê6¡Ë
EU Legislation Against Counterfeiting and Piracy in the Single Market¡ÊNo.2¡Ë
¡ÝFocused mainly on DIRECTIVE 2004/48/EC¡Ý
The Second Subcommittee,
The Second International
Affairs Committee
947¡Ê7¡Ë
Patent Exhaustion
¡ÝBetter late than never series¡Ê8¡Ë¡Ý
Sachiko NAKAMURA 957¡Ê7¡Ë
Product By Process Claim
¡ÝBetter late than never series¡Ê9¡Ë¡Ý
Chiharu SHIMIZU 1105¡Ê8¡Ë
Report on Protection of Software in China Software Committee 1207¡Ê9¡Ë
Double Patent
¡ÝBetter late than never series¡Ê10¡Ë¡Ý
Yasuhiro SAKATA 1219¡Ê9¡Ë
Examiner Interviews
¡ÝBetter late than never series¡Ê11¡Ë¡Ý
Akinori YAMAGUCHI 1361¡Ê10¡Ë
Inventions with Numerical Limitations
¡ÝBetter late than never series¡Ê12¡Ë¡Ý
Yuko HARA 1515¡Ê11¡Ë
PCT Reform The Third Subcommittee,
The Second International
Affairs Committee
1605¡Ê12¡Ë
Distinctiveness of Three-Dimensional Trademarks
¡ÝBetter late than never series¡Ê13¡Ë¡Ý
Koichi MURAKAMI 1617¡Ê12¡Ë

¡½ INTELLECTUAL PROPERTY MANAGEMENT ORGANIZATION AND ACTIVITIES OF¡§¡½

p. No.
NOK CORPORATION 109¡Ê1¡Ë
NIDEC CORPORATION 239¡Ê2¡Ë
TOAGOSEI CO., LTD. 409¡Ê3¡Ë
Nisshin Steel Co., Ltd. 543¡Ê4¡Ë
FDK CORPORATION 673¡Ê5¡Ë
DENKI KAGAKU KOGYO KABUSHIKI KAISHA 807¡Ê6¡Ë
STANLEY ELECTRIC CO., LTD 963¡Ê7¡Ë
KOBELCO CONSTRUCTION MACHINERY CO., LTD. 1111¡Ê8¡Ë
NIPPON KAYAKU CO., LTD. 1225¡Ê9¡Ë
ALPINE ELECTRONICS, INC. 1367¡Ê10¡Ë
KOITO MANUFACTURING CO., LTD. 1521¡Ê11¡Ë
Mitsubishi Tanabe Pharma Corporation 1625¡Ê12¡Ë

¡½ INTELLECTUAL PROPERTY Q & A ¡½

p. No.
No.110
Variety Registration System
Deputy Director
¡ÊLegal Charge¡ËATTORNEY
Plant Variety Protection
and Seed Division
Minisitry of Agriculture,
Forestry and Fisheries
Nobuyoshi TAKAHASHI
111¡Ê1¡Ë
No.111
Introduction and Operation of Online Application System via Internet
Intellectual Property Information
System Committee
545¡Ê4¡Ë
No.112
Patent Infringement in Russia
The Second International
Affairs Committee
675¡Ê5¡Ë
No.113
Basic Knowledge of Various Indications on Goods or Services
Fair Trade Committee 965¡Ê7¡Ë
No.114
Accelerated Appeal Examination System & Interrogatories Utilizing Reconsideration Reports From Examiners
Appeals Examination Policy
Planning Office,
Appeals Dept.,
Japan Patent Office
1227¡Ê9¡Ë
No.115
Trial Run of Super Accelerated Examination System
Administrative Affairs Division,
First Patent
Examination Department,
Japan Patent Office
1627¡Ê12¡Ë

¡½ ACTIVITIES OF JIPA ¡½

p. No.
JIPA IP Training Program in Taiwan, Korea and China;
¡ÈF3 Course Report¡É
The JIPA Overseas Trainee
Tour Group F3¡Ê¡Ç07¡Ë
677¡Ê5¡Ë
JIPA IP Training Program in the United States:
¡ÈF2 Course Report¡É
The JIPA Overseas Trainee
Tour Group F2¡Ê¡Ç07¡Ë
809¡Ê6¡Ë
JIPA IP Training Program in China;¡ÈF5 Course Report¡É The JIPA Overseas Trainee
Tour Group F5¡Ê¡Ç07¡Ë
969¡Ê7¡Ë
The Conference for Japan-China Corporate Cooperation Project for Corporate Cooperation Between
Japan and China
981¡Ê7¡Ë
Report of JIPA Delegation to EU¡Ê¡Ç08¡Ë JIPA delegation to EU¡Ê¡Ç08¡Ë 1229¡Ê9¡Ë
Copyright (C) Japan Intellectual Property Association All Rights Reserved.